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Brain injury after cardiac arrest is a significant contributor to morbidity and mortality. Selectively vulnerable
neuron populations undergo delayed neurodegeneration in the hours to days following reperfusion. Multiple
factors influence neuronal death after global brain ischemia, including excitatory synaptic input,
mitochondrial dysfunction, oxidative stress, inflammation, and disruption of intracellular Ca2+ homeostasis.
In hippocampal CA1 pyramidal neurons, these factors activate cell death via pathologic activity of calpains,
the family of Ca2+-dependent proteases, and calpain inhibition protects against neurodegeneration.
Therefore, we hypothesized that pathologic calpain activity is necessary and sufficient for neurodegeneration
in other selectively vulnerable neuron populations. In this thesis, the mechanism of calpain-mediated
neurodegeneration and optimization of current therapeutic approaches were explored using adult rat models
of brain ischemia. First, post-ischemic protease activity in mitochondria was characterized, specifically the
mechanism of electron transport chain subunit proteolysis. Complex I subunit NDUFB8 and Complex V
subunit  were cleaved in a Ca2+-independent manner in vitro by a mitochondrial cysteine protease. In
addition, NDUFB8 proteolysis was detected in hippocampal synaptosomes after global and focal brain
ischemia, indicating that proteolytic activity occurs in vivo and could play a role in post-ischemic
mitochondrial dysfunction. Second, the role of calpain activity in neurodegeneration of cerebellar Purkinje
cells was examined using an RNA interference approach to cause functional knockdown of calpain activity.
Surprisingly, knockdown of calpain activity did not significantly alter Purkinje cell neurodegeneration 48
hours after cardiac arrest, suggesting that alternative mechanisms may be involved in post-ischemic
neurodegeneration in the cerebellum. Finally, the optimal parameters of post-cardiac arrest therapeutic
hypothermia to minimize Purkinje cell loss were explored. Based on the parameters tested, therapeutic
hypothermia initiated 0-8 hours after return of spontaneous circulation and maintained for 24 or 48 hours
resulted in similarly significant neuroprotection compared to normothermia seven days after cardiac arrest in
the adult rat. In conclusion, these results paint a more complex picture of post-ischemic neurodegeneration,
which may include contributions of multiple pro-cell death stimuli rather than pathologic calpain activity
alone, and highlight the effectiveness of therapeutic hypothermia, which has broad effects on post-cardiac
arrest pathology that could contribute to neuroprotection.
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ABSTRACT 
 
NEURODEGENERATION AFTER CARDIAC ARREST: CELL DEATH 
MECHANISMS AND METHODS OF NEUROPROTECTION 
Michael G. Paine 
Robert W. Neumar 
Brain injury after cardiac arrest is a significant contributor to morbidity and mortality. 
Selectively vulnerable neuron populations undergo delayed neurodegeneration in the 
hours to days following reperfusion. Multiple factors influence neuronal death after 
global brain ischemia, including excitatory synaptic input, mitochondrial dysfunction, 
oxidative stress, inflammation, and disruption of intracellular Ca
2+
 homeostasis. In 
hippocampal CA1 pyramidal neurons, these factors activate cell death via pathologic 
activity of calpains, the family of Ca
2+
-dependent proteases, and calpain inhibition 
protects against neurodegeneration. Therefore, we hypothesized that pathologic calpain 
activity is necessary and sufficient for neurodegeneration in other selectively vulnerable 
neuron populations. In this thesis, the mechanism of calpain-mediated neurodegeneration 
and optimization of current therapeutic approaches were explored using adult rat models 
of brain ischemia. First, post-ischemic protease activity in mitochondria was 
characterized, specifically the mechanism of electron transport chain subunit proteolysis. 
Complex I subunit NDUFB8 and Complex V subunit  were cleaved in a Ca
2+
-
independent manner in vitro by a mitochondrial cysteine protease. In addition, NDUFB8 
proteolysis was detected in hippocampal synaptosomes after global and focal brain 
ischemia, indicating that proteolytic activity occurs in vivo and could play a role in post-
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ischemic mitochondrial dysfunction. Second, the role of calpain activity in 
neurodegeneration of cerebellar Purkinje cells was examined using an RNA interference 
approach to cause functional knockdown of calpain activity. Surprisingly, knockdown of 
calpain activity did not significantly alter Purkinje cell neurodegeneration 48 hours after 
cardiac arrest, suggesting that alternative mechanisms may be involved in post-ischemic 
neurodegeneration in the cerebellum. Finally, the optimal parameters of post-cardiac 
arrest therapeutic hypothermia to minimize Purkinje cell loss were explored. Based on 
the parameters tested, therapeutic hypothermia initiated 0-8 hours after return of 
spontaneous circulation and maintained for 24 or 48 hours resulted in similarly 
significant neuroprotection compared to normothermia seven days after cardiac arrest in 
the adult rat. In conclusion, these results paint a more complex picture of post-ischemic 
neurodegeneration, which may include contributions of multiple pro-cell death stimuli 
rather than pathologic calpain activity alone, and highlight the effectiveness of 
therapeutic hypothermia, which has broad effects on post-cardiac arrest pathology that 
could contribute to neuroprotection. 
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INTRODUCTION 
 
1.1. General overview of cardiac arrest 
 
Sudden cardiac arrest is among the most common causes of death in the United States. 
Estimates of the incidence of out-of-hospital cardiac arrest are in the range of 300,000 
adults per year (Nichol et al., 2008). Unfortunately, only 5% to 10% of patients who 
suffer an out-of-hospital cardiac arrest are successfully resuscitated and survive the 
incident without intervention beyond standard practices of the intensive care unit 
(Aufderheide et al., 2011; Stiell et al., 2011). Among survivors, only 50% have a good 
neurologic outcome, characterized by the ability of the patient to regain normal daily 
living without assistance (Aufderheide et al., 2011; Stiell et al., 2011). This provides a 
great opportunity and room for improvement of post-cardiac arrest care to minimize the 
severity of this debilitating injury. Of those who are resuscitated after out-of-hospital 
cardiac arrest and admitted to the hospital, brain injury is the most common cause of 
death (Laver et al., 2004). Therefore, it is imperative to focus on neuroprotection to 
improve survival and neurologic outcome after cardiac arrest. 
1.2. Selectively vulnerable neuron populations 
1.2.1. Hippocampus 
 
One intriguing aspect of cardiac arrest-induced brain injury is that not all of the brain 
responds equally to the temporary global loss of blood flow. Instead, specific neuron 
subtypes in various brain regions are more susceptible to neurodegeneration. These 
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groups of neurons that are most sensitive to global ischemic injury are called selectively 
vulnerable neuron (SVN) populations. The most thoroughly studied SVN population is 
the CA1 pyramidal neurons in the hippocampus (Larsson et al., 2001). Kirino (1982) first 
characterized delayed neuronal death after global ischemia. Since then, CA1 pyramidal 
neuron death has been commonly used as a representative of global ischemic injury. 
Protection against post-ischemic CA1 pyramidal neuron loss in animal models often 
correlates with improved performance in learning and memory behavioral tasks (Block 
and Schwartz, 1998; Milani et al., 1998). 
1.2.2. Cerebellum 
 
Next to CA1 pyramidal neurons in the hippocampus, the Purkinje cells of the cerebellum 
are among the most susceptible to excitotoxic injury after cardiac arrest (Horn and 
Schlote, 1992, Ng et al., 1989; Welsh et al., 2002). Extensive loss of Purkinje cells in 
human cerebellum after cardiac arrest has been well documented (Horn and Schlote, 
1992, Figure 1.1). However, the pathologic effect of Purkinje cell loss is poorly 
understood. Limited evidence suggests that loss of Purkinje cells after cardiac arrest 
could contribute to neurologic dysfunction, including post-hypoxic myoclonus (Welsh et 
al., 2002; Venkatesan and Frucht, 2006; Sarna et al., 2003). Examination of Purkinje cell 
death after global ischemia is made more difficult by the caveat that the frequently 
utilized animal models of transient forebrain ischemia do not injure the cerebellum 
(Kagstrom et al., 1983). Therefore, analysis of cerebellar neurodegeneration is typically 
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Figure 1.1. Degeneration and loss of Purkinje cells in human tissue after cardiac 
arrest. A-C: human cerebellar sections stained with hemotoxylin and eosin from 
patients who died 5 hours (A), 12 hours (B), and 13 days (C) after ROSC. D: The 
percentage of degenerating nuclei from the CA1 pyramidal layer of hippocampus, the 
Purkinje cell layer of cerebellum (yellow), and the frontal neocortex was quantified. 
Figure adapted from Horn and Schlote, 1992.  
performed using a whole-body cardiac arrest injury model (Tai et al., 2007, Welsh et al., 
2002). 
1.2.3. Other brain regions 
 
Several other SVN populations are less well studied. In the striatum, dorsolateral 
projection neurons and parvalbumin-positive striatal interneurons, but not neuropeptide 
Y-positive striatal interneurons, were lost after global ischemia in rats (Larsson et al., 
2001). In the thalamus, neurons in the somatosensory nucleus are lost, leading to 
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impaired thalamocortical circuitry (Shoykhet et al., 2012). In the neocortex, pyramidal 
neurons in layers III and V are most sensitive to global ischemic insult (Sieber et al., 
1995). Each of these regions may contribute to neurologic dysfunction and mortality after 
cardiac arrest. 
1.3. Factors involved in selective vulnerability 
 
A multitude of factors appear to influence the relative vulnerability of different neuron 
populations to transient ischemia and reperfusion. Some of these factors, including the 
nature of excitatory input to the neuron population, blood flow to the region of the brain, 
and inflammation at the site of injury, are extrinsic to the neuron populations, while 
others, such as the magnitude of and response to oxidative stress and Ca
2+
 influx, are 
intrinsic to the neurons. Although each of these factors will be discussed individually, 
there is likely to be considerable overlap in their contribution to neuronal death.  
1.3.1. Excitatory input to SVN populations 
 
One aspect of SVN populations that appears to be consistent is that, compared to other 
neuron populations, SVN populations possess a greater extent of excitatory synapses, 
which could be more likely to result in overexcitation under extreme stimulation. CA1 
pyramidal neurons of the hippocampus are a part of the basic hippocampal circuit, in 
which the granule cells of the dentate gyrus project to pyramidal neurons in CA3, which 
then project to the pyramidal neurons of CA1. CA1 pyramidal neurons project to the 
subiculum and out of the hippocampus to the entorhinal cortex. All three of the main 
components of this circuit extend excitatory projections, which allows for overexcitation 
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in some pathologic circumstances such as seizure and ischemia-reperfusion injury 
(Griffiths et al., 1982; Deshpande et al., 1987). 
Cerebellar Purkinje cells are a critical component of the cerebellar circuit. These neurons 
possess extensive dendritic arborizations, which receive inputs from two sources. The 
parallel fiber pathway originates from cerebellar granule cells and many thousand parallel 
fibers pass through and synapse with the distal dendritic arbors of each Purkinje cell. 
Alternatively, the climbing fiber pathway originates from the inferior olive and sends a 
single projection with multiple synapses to an individual Purkinje cell’s proximal 
dendrites and soma. These dual synaptic inputs provide the basis for the refinement and 
performance of fine motor control function of the cerebellum. Some evidence suggests 
that the climbing fiber input from the inferior olive could cause excitotoxic stimulation of 
the Purkinje cells to lead to their neurodegeneration (Welsh et al., 2002). 
1.3.2. Cerebral blood flow 
 
Variations in blood flow to different regions of brain tissue could contribute to the 
severity of ischemia-reperfusion injury. First, it is important to understand regional 
cerebral blood flow (CBF) in the baseline context. CBF in anesthetized animals appears 
to be similar throughout all regions of the brain, estimated in the range of 0.7-0.8 ml min
-
1
 g
-1
 (Goldman and Sapirstein, 1973; Reivich et al., 1969). In the conscious state, regional 
CBF is more variable, between 0.8-1 ml min
-1
 g
-1
 (Goldman and Sapirstein, 1973). 
Interestingly, in this study the dorsal hippocampus was at the low end of the range of 
CBF in both the conscious and anesthetized state (Goldman and Sapirstein, 1973). In 
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addition, neuronal stimulation is known to correlate with an uptick in CBF specifically in 
the activated region (Sokoloff, 1961).  
Upon reperfusion after transient ischemia, total CBF elevates to hyperemia. However, 
there is wide regional variation in this effect (Kagstrom et al., 1983; Lin et al., 1979). In 
fact, midbrain regions that are susceptible to ischemia-reperfusion injury, particularly the 
hippocampus, achieve a lower-than-baseline CBF upon reperfusion, which can include 
areas of no-reflow (Kagstrom et al., 1983). However, in the cerebellum there is very little 
change in regional CBF between baseline and post-ischemic reperfusion (Kagstrom et al., 
1983). As reperfusion continues, regional CBF moderates toward baseline levels. The 
timecourse of CBF recovery depends upon the duration—and model—of ischemia, with 
longer ischemia duration correlating with a longer period until moderation of CBF and 
larger areas of no-reflow in some models (Kagstrom et al., 1983; Lin, 1975). 
Further evidence supports a role of CBF in the severity of ischemia-reperfusion injury. 
Pre-treatment with an activator of the protein kinase C- pathway alleviated the post-
reperfusion modulation in hippocampal CBF and protected against CA1 pyramidal 
neuron death (Della-Morte et al., 2011). In addition, brief ischemia-reperfusion insults 
given just before (ischemic preconditioning) or after (ischemic post-conditioning) 
ischemia-reperfusion injury have been demonstrated to moderate the post-reperfusion 
CBF response as well as reduce hippocampal injury (Nakamura et al., 2006; Wang et al., 
2008). Therefore, the correlation between recovery of normal hippocampal CBF and the 
protection of CA1 pyramidal neurons from post-ischemic neurodegeneration suggests 
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that ischemia-reperfusion-mediated alterations in CBF could contribute to neuronal 
injury, particularly in the hippocampus. 
1.3.3. Inflammation 
 
In the brain, the inflammatory response to ischemia-reperfusion injury is principally 
mediated by activated microglia. In the resting state, microglia exist throughout the CNS 
tissue and monitor the extracellular space for the presence of molecules indicating neural 
injury, such as intracellular proteins, pro-inflammatory factors, and foreign particles. 
When microglia encounter such species, they proliferate, migrate to the injury site, and 
differentiate into phagocytic cells. Within the first 8 hours after global ischemia, neurons 
express the interleukin-1 receptor to attract glial cell types, including microglia, 
expressing interleukin 1-β (Sairanen et al., 1997). Activated microglia are detected in 
SVN populations including hippocampal CA1, peaking between 4-6 days post-injury but 
lasting up to 2-4 weeks post-injury (Stoll et al., 1998; Orzyłowska et al., 1999).  
Inflammation plays a somewhat complex role in the events following ischemia-
reperfusion injury. Activated microglia benefit the injured tissue via phagocytosis of 
cellular debris (Danton et al., 2003). In addition, inflammatory signaling may promote 
neurogenesis and proliferation of new neurons at the injured region in the hippocampus 
via cyclooxygenase-2, although inhibition of this enzyme has been shown to be 
neuroprotective (Sasaki et al., 2003; Nakayama et al., 1998). However, activated 
microglia promote the release of neurotoxic species, including superoxide, nitric oxide, 
and their product peroxynitrite, which could damage neurons that may otherwise survive 
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the ischemic insult (reviewed in Neumar, 2000; Yang et al., 2008). Multiple studies have 
demonstrated that inhibition of the inflammatory response reduces global ischemic injury 
severity, and that exacerbation of the inflammatory response increases injury severity, in 
the hippocampus (Yrjänheikki et al., 1998; Ooboshi et al., 2005; Walker and Rosenberg, 
2009; Xuan et al., 2012; Hazelton et al., 2010).  
1.3.4. Ca
2+
-mediated cell death mechanisms in ischemia-reperfusion 
 
The excitatory inputs to the hippocampal and cerebellar circuits described above consist 
of glutamatergic synapses. AMPA receptors are glutamate-activated Na
+
 channels that 
generate a depolarizing current when activated. NMDA receptors are Ca
2+
-permeable 
glutamate-activated channels. The Ca
2+
-permeability of NMDA receptors is blocked by 
Mg
2+
 at resting membrane potential, and the cellular membrane must be depolarized to 
release this inhibition and allow extracellular Ca
2+
 entry. Neuronal depolarization 
activates voltage-gated Na
+
 channels in the membrane, and intracellular Ca
2+
 acts as a 
second messenger in multiple signaling pathways, including activation of the IP3 receptor 
to release Ca
2+
 from its intracellular stores in the endoplasmic reticulum (ER). If left 
unchecked, intracellular Ca
2+
 (Ca
2+
i) elevation acts in a feed-forward mechanism. 
However, neurons possess multiple strategies to maintain Ca
2+
i homeostasis (reviewed in 
Dong et al., 2006). The Na
+
/Ca
2+
 exchanger and the plasma membrane Ca
2+
 ATPase 
extrude Ca
2+
 from the cytosol, the former with a larger capacity and the latter with a 
higher affinity (reviewed by Guerini et al., 2005). The sarcoplasmic/endoplasmic 
reticulum Ca
2+
 ATPase imports Ca
2+
i from the cytosol to the ER (Dong et al., 2006; 
Sepúlveda and Mata, 2005). If mitochondria are in a polarized state, they can buffer large 
9 
 
amounts of free Ca
2+
i via the mitochondrial Ca
2+
 uniporter and their phosphate pool in the 
matrix, which can precipitate free Ca
2+
 (Dong et al., 2006; Kannurpatti et al., 2000). In 
addition, glial and neuronal glutamate transporters limit the time that AMPA and NMDA 
receptors are activated by glutamate in the synaptic cleft (reviewed by Camacho and 
Massieu, 2006).  
Under physiologic conditions, these mechanisms are sufficient to control Ca
2+
i levels 
such that spikes in Ca
2+
i activate second messenger pathways without causing an 
excitotoxic buildup of Ca
2+
i. However, in an energy-depleted environment such as 
ischemia, Ca
2+
 extrusion methods become exhausted and Ca
2+
i levels rise to potentially 
toxic levels (Silver and Erecinska, 1998). In the case of resuscitation after cardiac arrest, 
the ischemic tissue is reperfused, allowing cells to produce the energy required to regain 
Ca
2+
i homeostasis (Silver and Erecinska, 1998). In a transient ischemia, such as cardiac 
arrest, the vast majority of neurons and glia are capable of withstanding the brief Ca
2+
i 
overload (Dux et al., 1987). However, in SVN populations, a delayed secondary wave of 
increased Ca
2+
i occurs in these neurons between 24-48 hours post-ROSC, leading to 
excitotoxic neurodegeneration (Dux et al., 1987; Neumar et al., 2001). The underlying 
mechanisms of this secondary Ca
2+
i wave require further investigation.  
Multiple factors may play a role in Ca
2+
i-induced toxicity. First, Dux et al. (1987) found 
that mitochondrial Ca
2+
 concentration ([Ca
2+
]m) follows a similar spiking pattern to Ca
2+
i 
concentration after reperfusion. These spikes in [Ca
2+
]m can cause depolarization of the 
mitochondrial membrane, inhibiting ATP production and enhancing ROS generation 
(Canevari et al., 1999; Piantadosi and Zhang, 1996; Votyakova and Reynolds, 2005; 
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Friberg et al., 2002). Upon reperfusion, resumption of mitochondrial activity induces a 
surge in production of reactive oxygen species (ROS), which are capable of damaging 
lipids, proteins, and DNA (Piantadosi and Zhang, 1996). In vitro studies have 
demonstrated that increased [Ca
2+
]m impaired electron transport chain (ETC) function and 
increased ROS release (Votyakova and Reynolds, 2005). Overexpressing enzymes that 
break down ROS is neuroprotective in animal models of injury (Weisbrot-Lefkowitz et 
al., 1998; Gu et al., 2004). Alternatively, mild uncoupling of mitochondria by 
overexpressing endogenous proteins or injecting exogenous uncouplers reduces [Ca
2+
]m 
accumulation and ROS production and enhances neuronal survival (Korde et al., 2005; 
Mattiason et al., 2003). Therefore, there appears to be a direct link between post-injury 
increases in Ca
2+
i concentration, [Ca
2+
]m, ROS production, mitochondrial dysfunction, 
and cell death. 
Additionally, if the buffering capacity of mitochondria is overwhelmed, the increase in 
mitochondrial free Ca
2+
 causes swelling of the matrix that leads to opening of the 
mitochondrial permeability transition pore, which alleviates the Ca
2+
-induced swelling 
but also releases pro-cell death factors such as Omi, apoptosis inducing factor (AIF), and 
cytochrome c (Dong et al., 2006). Third, Ca
2+
 depletion from the ER can activate a pro-
apoptotic ER stress response (Mekahli et al., 2011). Finally, calpains, the family of Ca
2+
-
dependent proteases, can induce cell death when activated by high Ca
2+
i via proteolysis of 
its substrates. The calpain system and its role in excitotoxic neuronal death are described 
below. 
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Figure 1.2. Domain structure of brain calpain isoforms. From Bevers and Neumar 
(2008). Classical calpains 1 and 2 require heterodimerization with calpain small 
subunit 1 (Capns1) to form an active enzyme, µ-calpain and m-calpain, respectively. 
Calpain 3 possesses a Ca
2+
-binding EF-hand domain, but does not require 
heterodimerization with Capns1 for activity. The C-terminal domains of the atypical 
calpains 5 and 10 do not appear to possess Ca
2+
-binding domains, and the activity and 
Ca
2+
-dependence of these calpain isoforms is not completely understood. 
1.4. Role of calpain activity in neurodegeneration after cardiac arrest 
 
Calpains are a family of Ca
2+
-dependent cysteine proteases that specifically cleave 
proteins in a limited manner to alter their function. The physiological roles of calpains 
include cytoskeletal remodeling, cell cycle progression, and long-term potentiation (Goll 
et al., 2003; Mellgren et al., 2007). Additionally, calpain activity plays a pathologic role. 
Pathologic calpain activity has been associated with neurodegeneration in numerous 
models of acute and chronic neurodegeneration, including global and focal ischemia 
(Neumar et al., 2001; Markgraf et al., 1998), traumatic brain and axonal injury (Schoch 
et al., 2012; Ma et al., 2012), Alzheimer’s disease (Higuchi et al., 2012; Ferreira and 
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Bigio, 2011), and Parkinson’s disease (Vosler et al., 2008).  
1.4.1. The calpain system in the brain 
 
Of the 15 calpain isoforms discovered, 5 of these (1, 2, 3, 5, and 10) have been detected 
in brain tissue. The classical calpains 1 and 2 are nearly ubiquitously expressed and are 
the most thoroughly studied. Each requires heterodimerization with calpain small subunit 
1 (Capns1) for activity; heterodimerized forms are referred to as - and m-calpain, 
respectively (Bevers and Neumar, 2008). In a cell-free system, µ-calpain required a range 
of 3-50 µM free Ca
2+
 for half-maximal activity, while m-calpain required 400-800 µM 
free Ca
2+
 (Goll et al., 2003). Calpains 1 and 2 possess Ca
2+
-binding EF hand domains in 
their C-terminal domain IV. Additionally, the active site contains Ca
2+
-binding domains 
that are thought to be critical for alignment of the active site for proteolytic activity 
(Suzuki et al., 2004). Calpain 3 is most predominantly expressed in skeletal muscle, and 
mutations of this gene are implicated in limb-girdle muscular dystrophy type 2A (Richard 
et al., 1995). Calpains 5 and 10 are termed atypical calpains because they lack a Ca
2+
-
binding domain IV at the C-terminus of classical calpains, replaced by a C-terminal 
domain T (Bevers and Neumar, 2008). Additionally, calpain 10 does not contain the 
active site Ca
2+
-binding domains of the typical calpain isoforms (Moldoveanu et al., 
2002). Calpain activity is regulated by the endogenous inhibitor calpastatin, which 
possesses a repeated domain structure that allows each calpastatin molecule to inhibit up 
to four calpain molecules (Maki et al., 1987). 
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1.4.2. Mechanistic role of calpain activity in global brain ischemia 
 
Specific and sensitive detection of calpain activity has been achieved by utilizing 
antibodies directed against the exposed calpain cleavage site of calpain substrates such as 
spectrin and the inositol-1,4,5-triphosphate (IP3) receptor subtype 1 (Roberts-Lewis et al., 
1994; Kopil et al., 2011). Using this approach, post-ischemic calpain activity has been 
demonstrated in the hippocampal CA1 sector, cerebral cortex, striatum, and Purkinje cells 
of the cerebellum—all of which are SVN populations—in a timecourse that correlates 
with neurodegeneration (Neumar et al., 2001; Kopil et al., 2011). 
The critical role of calpain activity in the hippocampus in neurodegeneration after global 
brain ischemia has been demonstrated using a variety of techniques. Multiple calpain 
inhibitor drugs have proven effective in reducing ischemia-reperfusion injury in animal 
models, even when given up to 22 hours after reperfusion (Lee et al., 1991; Li et al., 
1998; Frederick et al., 2008). One important caveat of these calpain inhibitor compounds 
is their non-specific activities (Wang and Yuen, 1999). Therefore, genetic manipulations 
of the calpain system have been used to isolate their role in the mechanisms of 
neurodegeneration. Overexpression of the specific endogenous inhibitor calpastatin has 
been used to inhibit calpain activity and prevent neurodegeneration (Cao et al., 2007).  
Alternatively, RNA interference has been used to block activity of specific calpain 
isoforms. Recent studies have demonstrated that calpain 1 is the critical isoform causing 
neurodegeneration in hippocampal CA1 pyramidal neurons in a rat model of global brain 
ischemia (Bevers et al., 2010), while calpain 2 is the isoform activated in primary 
hippocampal neurons subjected to NMDA excitotoxicity (Bevers et al., 2009). 
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It is important to note that most in vivo studies of neurodegeneration after global ischemia 
have focused on hippocampal CA1 pyramidal neuron loss. Exploration of the role of 
calpain activity in post-ischemic neurodegeneration in other SVN populations is 
necessary to determine whether blockade of calpain activity alone would be sufficient as 
a therapeutic strategy after cardiac arrest. 
1.4.3. Timecourse of calpain activity in the brain after global ischemia 
 
Due to the raised Ca
2+
i levels during and immediately after the ischemic event, calpain 
activity has been detected as early as 15 minutes after reperfusion (Yokota et al., 1995; 
Roberts-Lewis et al., 1994; Neumar et al., 2001). However, this period of calpain activity 
is not sufficient to induce immediate neuronal death, and neurons recover from the 
ischemic event and degrade the calpain cleavage products. Upon the secondary wave of 
Ca
2+
i entry, calpain-cleaved substrates accumulate until neuronal death. The delayed 
calpain activity in the hippocampus and cortex begins between 24-48 hours after 
reperfusion, leading to neurodegeneration between 48-72 hours (Neumar et al., 2001; 
Siman et al., 2005). However, in the cerebellum, this process appears to be accelerated, 
such that calpain activity in Purkinje cells peaks by 24 hours and neurodegeneration 
begins between 24-48 hours after reperfusion (Kopil et al., 2011; unpublished 
observations). Overall, the mechanisms underlying the timing of the secondary Ca
2+
i 
overload and delayed calpain activity are poorly understood, but this time period may 
provide a therapeutic window during which calpain inhibition could be initiated to 
prevent neuronal death (Frederick et al., 2007). 
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1.4.4. Localization of pathologic calpain activity 
 
Cytosol 
Classical calpains 1 and 2, as well as calpain 3, are expressed in the cytosol (Bevers et 
al., 2008). These isoforms have access to cytosolic substrates, as well as transmembrane 
and membrane-associated proteins on the plasma membrane, the ER membrane, and the 
synapse. As reviewed by Bevers et al. (2008), calpains cleave substrates involved with 
post-synaptic reorganization, Ca
2+
i regulation, and signaling cascades. Proteolysis of 
many of these substrates—including but not limited to p53, p35, collapsin response 
mediator proteins, IP3 receptor, Bid, AIF, and caspase 7—converts these molecules 
towards a pro-cell death function (Bevers et al., 2008). It is likely that convergence of 
multiple cell death mechanisms via calpain activity could cause calpain-mediated 
toxicity. 
Mitochondria 
At the time of their initial discovery and characterization, calpains were thought to have 
purely cytosolic localization. Recently, calpain 1 was detected in mitochondria (Garcia et 
al., 2005; Kar et al., 2007). Conflicting studies have reported calpain 1 to be present in 
the intermembrane space (IMS) (Badugu et al., 2008) or the IMS face of the inner 
membrane (IM) (Kar et al., 2008). Calpain 2 has been reported to be present in the IMS 
of rat liver mitochondria (Ozaki et al., 2009). The regulatory subunit Capns1 has also 
been found in mitochondria (Badugu et al., 2008; Ozaki et al., 2007; Kar et al., 2007). 
Arrington et al. (2006) found calpain 10 to be specifically localized to the mitochondrial 
matrix in rabbit and rat renal cortical mitochondria. This group has also demonstrated that 
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three calpain 10 isoforms are expressed in mitochondria (Giguere et al., 2008). In 
addition, the calpain inhibitor calpastatin has been detected in mitochondria of bovine 
pulmonary smooth muscle, suggesting that mitochondrial calpains may be regulated a 
manner analogous to cytosolic mechanisms (Kar et al., 2007; Kar et al., 2008). 
The best-characterized mitochondrial calpain substrate is AIF, which is bound to the IMS 
face of the IM (Polster et al., 2005). There is evidence that calpain-mediated cleavage of 
AIF generates a truncated form that translocates to the nucleus to initiate cell death after 
global brain ischemia (Cao et al., 2007). Polster et al. (2005) demonstrated that -calpain 
cleaves AIF in a Ca
2+
-dependent manner. Further studies of the ability of mitochondrial 
-calpain to cleave AIF have provided conflicting results (Joshi et al., 2009; Ozaki et al., 
2009). Additionally, recent evidence suggests that AIF proteolysis by calpain is not 
necessary for nuclear translocation and activation of AIF-induced cell death (Wang et al., 
2009). 
Two independent studies report calpain-mediated cleavage of ETC subunits. Goudenege 
et al. (2007) detected a calpain-cleaved fragment of ATP synthase/Complex V subunit  
(Complex V), part of the F0 complex in the matrix. Arrington et al. (2006) found Ca
2+
-
dependent cleavage of two subunits of Complex I, NADH dehydrogenase (ubiquinone) 
flavoprotein 2 (NDUFV2) and NADH dehydrogenase (ubiquinone) 1 β subcomplex 8 
(NDUFB8) (originally reported as ND6; Capaldi, 2008). In addition, reduced levels of 
purported calpain 10 substrates NDUFB8 and Complex V subunit β have been reported 
in models of acute kidney injury (Funk and Schnellmann, 2011). 
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While multiple studies have detected calpain-mediated proteolytic fragments in 
mitochondria (Polster et al., 2005; Goudenege et al, 2007; Arrington et al., 2006; 
Arrington and Schnellman, 2008; Funk and Schnellmann, 2011), only proteolysis of AIF 
has been detected in brain mitochondria. Therefore, further studies of mitochondrial 
Figure 1.3. Hypothetical model of mitochondrial calpain activity after ischemic 
brain injury. Pathways known to occur post-ischemia are in blue, and hypothesized 
pathways are in red. Ischemia-reperfusion causes elevated intracellular Ca
2+
, which is 
absorbed by mitochondria. Elevated [Ca
2+
]m can induce MPT, reduce ATP synthesis, 
and increase ROS production. Calpains cleave AIF post-ischemia to induce cell death. 
Calpain-mediated cleavage of ETC subunits in Complex I (NDUFV2 and NDUFB8) 
and Complex V ( and β) have been detected in vitro and/or in vivo. As shown, post-
ischemic increases in [Ca
2+
]m could lead to activation of mitochondrial calpains to 
contribute to post-ischemic cell death via cleavage of ETC subunits, resulting in ETC 
complex dysfunction, reduced ATP synthesis, and increased ROS production. 
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calpain activity in the brain are needed to elucidate its role in mitochondrial dysfunction 
and neurodegeneration.  
Taken together, these results suggest that mitochondrial calpains may be important 
mediators of mitochondrial homeostasis, and that alteration of the mitochondrial calpain 
system could contribute to mitochondrial dysfunction (Figure 1.3). However, further 
study is needed to characterize mitochondrial calpain activity. 
1.5. Therapeutic hypothermia 
 
Currently, the only therapy proven in randomized clinical controlled trials to improve 
survival rate and neurologic outcome after cardiac arrest is therapeutic hypothermia 
(Bernard et al., 2002; Hypothermia after Cardiac Arrest Study Group, 2002). In these 
studies, survival rate and neurologic outcome were improved by 30-50%. Presently, the 
standard operating procedure for therapeutic hypothermia is quite variable among 
treatment centers, but current guidelines recommend cooling body temperature from 37 
o
C to 32-33 
o
C once the patient is resuscitated and stabilized (ideally within 4 hours of the 
incident) for a period of 12-24 hours, at which time the patient is passively or actively re-
warmed to normothermic temperature (Peberdy et al., 2010). Numerous studies utilizing 
a similar hypothermia regimen have been successful in human patients (Belliard et al., 
2007; Castrejon et al., 2009).  However, the optimal therapeutic hypothermia regimen has 
yet to be elucidated. Additional studies in translational models and clinical settings 
should provide beneficial insight into the maximal therapeutic benefit of hypothermia 
treatment. 
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Although the definitive mechanism of neuroprotection is not known, post-ischemic 
therapeutic hypothermia has multiple effects that could contribute to neuronal survival. 
First, the basal metabolic rate is reduced to 50-65% of normothermia (reviewed in 
Polderman, 2009; Erecinska et al., 2003). The inflammatory response is alleviated due to 
hypothermia treatment, as evidenced by a reduction in activated microglia in the 
hippocampus (Webster et al., 2009). Free radical production is mitigated after ischemia, 
although these studies performed therapeutic hypothermia throughout the ischemia-
reperfusion period (Globus et al., 1995; Horiguchi et al., 2003). Disruption of Ca
2+
i 
homeostasis is also attenuated by therapeutic hypothermia (Polderman, 2009). It is likely 
that a combination of these factors contributes to neuroprotection by therapeutic 
hypothermia. However, a better understanding of these individual mechanisms could help 
optimize therapeutic hypothermia treatment and aid in the development of novel 
therapeutic strategies. 
1.6. Summary 
 
Brain injury after cardiac arrest causes significant morbidity and mortality. Multiple 
mechanisms appear to contribute to neuronal injury and loss.  One valuable approach to 
elucidate neuronal death pathways after cardiac arrest is to examine individual 
neurodegeneration mechanisms in order to determine the causal pathway(s) of post-
ischemic neurodegeneration. Previous studies have indicated that cytosolic calpain 
activity plays a critical role in post-ischemic neurodegeneration in the CA1 pyramidal 
neurons of the hippocampus. To expand upon our current understanding, the role of 
calpain activity in post-ischemic mitochondrial dysfunction is analyzed. Next, the role of 
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calpain activity in cerebellar Purkinje cell neurodegeneration is examined. An alternative 
approach to improve outcome in the near-term is to focus on optimizing existing 
therapeutic strategies. Therefore, the optimal parameters of therapeutic hypothermia in 
the cerebellum are explored. The results of these studies provide valuable insight into 
neurodegeneration mechanisms and could have broad clinical impact, as these cell death 
pathways are found in a variety of diseases. 
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PROTEOLYSIS OF ELECTRON TRANSPORT CHAIN SUBUNITS BY AN 
ENDOGENOUS MITOCHONDRIAL CYSTEINE PROTEASE 
 
2.1. Introduction 
Neurodegeneration caused by ischemic brain injury is a major contributor to death and 
disability (American Heart Association Statistics Committee and Stroke Statistics 
Subcommittee, 2011). One important contributor to the mechanisms of post-ischemic 
neurodegeneration is mitochondrial dysfunction. During the ischemic event, oxygen and 
ATP in brain tissue are exhausted, resulting in depolarization of neuronal membranes 
(Silver and Erecinska, 1998). Upon reperfusion, oxidative metabolism restarts, causing 
elevated reactive oxygen species (ROS) production and mitochondrial swelling due to 
absorption of excess intracellular Ca
2+
 (Dux et al., 1987; Starkov et al., 2004; Nicholls, 
2009; Racay et al., 2009; Sims and Muyderman, 2009). Although ion gradients return to 
baseline in the penumbra after focal ischemia and in selectively vulnerable neurons after 
global ischemia, reduced energy metabolism and increased ROS production perpetuate 
(Silver and Erecinska, 1998; Starkov et al., 2004; Piantadosi and Zhang, 1996; Racay et 
al., 2009; Friberg et al., 2002). Taken together, these disruptions in mitochondrial 
function and mitochondrial Ca
2+
 homeostasis can lead to opening of the mitochondrial 
permeability transition pore, causing the release of cell death factors such as apoptosis 
inducing factor to induce neurodegeneration (Plesnila et al., 2004; Cao et al., 2003). 
A recently discovered potential mechanism of mitochondrial dysfunction is proteolysis of 
electron transport chain (ETC) subunits by the calpain family of proteases. Of the 15 
known calpain isoforms, calpains 1 and 10 and the endogenous calpain inhibitor 
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calpastatin have been detected in mitochondria (Garcia et al., 2005; Arrington, et al., 
2006; Kar et al., 2007; Giguere et al., 2008). However, only calpain 1 has been 
demonstrated to be present in brain mitochondria, and further study is required to 
elucidate the localization and activity of mitochondrial calpains and calpastatin in 
neurons (Garcia et al., 2005).  
Mitochondrial calpain-mediated ETC subunit proteolysis has been reported in vitro and 
in vivo. Arrington et al. (2006) detected cleavage of two inner membrane subunits of 
Complex I, NDUFV2 and NDUFB8 (originally reported as ND6—see Capaldi, 2008), 
causing reduced activity of Complex I in mitochondria from rabbit and rat renal cortex. 
Because calpain 10 is the only known matrix cysteine protease, this group concluded that 
this isoform was responsible for proteolysis. In addition, reduced levels of purported 
calpain 10 substrates NDUFB8 and Complex V subunit β have been reported in models 
of acute kidney injury (Funk and Schnellmann, 2011). Using an RNA interference 
approach, Goudenege et al. (2007) detected a calpain 2-mediated proteolytic fragment of 
ATP synthase/Complex V subunit  (Complex V), part of the F0 complex in the matrix, 
in Ca
2+
 ionophore-treated C2C12 mouse myotube lipid rafts. However, this result is not 
supported with any evidence that calpain 2 is localized to mitochondria. The regulation of 
mitochondrial calpain activity is not completely understood. While calpastatin-mediated 
inhibition of calpain 1 is well documented, the inhibitory effect of calpastatin on calpain 
10 has not been reported, and based on the atypical structure of calpain 10, calpastatin 
may not inhibit this isoform (Croall and Ersfield, 2007). Taken together, these results 
suggest that mitochondrial calpains may be important mediators of mitochondrial 
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homeostasis, and that alteration of the mitochondrial calpain system could contribute to 
the altered energy metabolism and increased ROS production related to post-ischemic 
mitochondrial dysfunction. However, further study is needed to characterize 
mitochondrial calpain activity.  
In this study, we set out to test the hypothesis that mitochondrial calpains cleave ETC 
subunits in a manner consistent with classical calpain activity. We first examined the 
conditions required to induce and inhibit ETC subunit proteolysis in isolated 
mitochondria from brain, heart and kidney. In addition, we examined whether ETC 
subunit proteolysis could be detected after brain ischemia and reperfusion. Our results 
suggest that an endogenous mitochondrial cysteine protease can cleave ETC subunits in 
vitro and in vivo.  The characteristics of the protease activity are not consistent with the 
activity of calpain 1 or 2, but are potentially consistent with the atypical isoform calpain 
10. 
2.2. Materials and Methods 
2.2.1. Fractionation of Rat Forebrain 
 
Adult male Long Evans rat (Harlan Laboratories) forebrain was extracted and placed in 
1g:10 mL MSHE buffer (0.22M mannitol, 70mM sucrose, 0.5mM EGTA, 2mM K-
HEPES, pH 7.2) with 0.1% fatty acid-free bovine serum albumin (BSA) (MSHE+BSA) 
and 1% protease inhibitor cocktail (P2714, Sigma), minced, and homogenized using a 
Dounce homogenizer. Homogenate was centrifuged at 1,000 g for 10 minutes at 4 
o
C. 
The supernatant was taken and centrifuged at 10,000 g for 10 minutes at 4 
o
C. To obtain 
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purified cytosol, the supernatant from the second centrifugation was centrifuged at 
100,000 g for 1 hour at 4 
o
C, and the resulting supernatant was collected. To obtain 
purified mitochondria, the pellet from the second centrifugation was resuspended in 
MSHE+BSA and layered above a 4x volume of 30% Percoll solution (30% v/v Percoll, 
0.22M mannitol, 25mM K-HEPES, 1mM EGTA, 0.1% fatty acid-free BSA) for gradient 
centrifugation at 100,000 g for 30 min at 4 
o
C. After this step, the mitochondrial band 
was removed and washed once each in MSHE+BSA and MSHE buffer with 
centrifugation at 10,000 g for 10 minutes at 4 
o
C. Purified mitochondria were 
resuspended at 10.0mg/mL in mitochondria buffer (125mM KCl, 20mM K-HEPES, 
2mM KH2PO4, 10M EGTA, pH 7.2) and stored at -20 
o
C. 
2.2.2. Isolation of mitochondria from rat kidney cortex and heart tissue 
 
Adult male Long Evans rat kidney cortex was excised and minced in 1g:10mL 
MSHE+BSA plus 1% protease inhibitor cocktail. The minced tissue was homogenized 
using a Potter-Elvenjem homogenizer at 1600 rpm. 
Adult male Long Evans rat heart tissue was minced in 1g:10 mL Buffer A (100mM KCl, 
50mM Tris-HCl, 5mM MgCl2, 1mM EDTA, 1mM ATP, 0.5% fatty acid-free BSA, pH 
7.5) and briefly homogenized using a Potter-Elvenjem homogenizer at 1600 rpm to 
release subsarcolemmal mitochondria. To release interfibrillar mitochondria, the 
homogenized heart tissue was incubated in 4mg trypsin/g tissue in Buffer A on ice for 2 
minutes with stirring.  Then, 4mg/g tissue soybean trypsin inhibitor was added, and the 
sample was re-homogenized at 1600 rpm. 
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Rat kidney cortex and heart tissue homogenates were treated in the same manner as the 
forebrain homogenate described above to obtain purified mitochondria. 
2.2.3. Generation of freeze-thawed mitochondria and in vitro proteolytic activity 
experiments 
 
Purified mitochondria were subjected to three cycles of freeze-thaw prior to use. Freeze-
thawed mitochondria and reaction samples were pre-incubated for 15 minutes at 37 
o
C 
prior to the start of each reaction. All proteolytic activity assays were performed with a 
minimum of three trials. Mitochondria were incubated at 1.00 mg/mL in mitochondria 
buffer plus 2mM BME (unless otherwise noted) at 37 
o
C under the conditions described 
for each experiment. For examination of pH dependence, the HEPES-based mitochondria 
buffer was not suitable for a pH 6.0 solution. Therefore, after the first freeze-thaw cycle, 
mitochondria were split into three aliquots and centrifuged at 10,000 g for 10 minutes at 4 
o
C. One aliquot of mitochondria was resuspended in the same volume of mitochondria 
buffer, one aliquot was resuspended in 0.1M potassium phosphate (KPi) pH 6.0, and one 
aliquot was resuspended in 0.1M KPi pH 7.2. These mitochondria samples were then 
subjected to two more freeze-thaw cycles for proteolytic activity experiments. Protease 
inhibitors used in this study include: MDL-28170 (Biomol); calpeptin, Z-FF-FMK, and 
human calpastatin peptide (EMD Biosciences); CA-074 (Bachem); and CYGAK (a 
generous gift from Dr. Rick Schnellmann, Medical University of South Carolina).  
2.2.4. Western Blot 
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Western blot was performed as previously described (Bevers et al., 2009).  SDS-PAGE 
was performed using 15-well 4-20% Tris-glycine precast gels (Invitrogen) at 125 V. 
Separated proteins were transferred to nitrocellulose membrane for 1-hour at 425 mA. 
Molecular weights were estimated using Precision Plus Protein Kaleidoscope Standards 
(Bio-Rad). Primary antibodies used include rabbit polyclonal antibodies to calpain 1 
(generated by our laboratory), calpains 2 and 10 (Triple Point Biologics), and calpains 3 
and 5 (Abcam), rabbit polyclonal anti- VDAC (Affinity Bioreagents), rabbit polyclonal 
anti-calpain-cleaved -spectrin (Ab38, provided by Dr. Robert Siman, University of 
Pennsylvania), mouse monoclonal anti-actin AC-40 (Sigma), mouse monoclonal anti-
NDUFB8 (Mitosciences), and mouse monoclonal anti-Complex V (Molecular Probes). 
Horseradish peroxidase-linked goat anti-mouse and anti-rabbit (PerkinElmer) secondary 
antibodies were used. Western blots were visualized using enhanced chemiluminescence 
solution (PerkinElmer). 
2.2.5. Rat model of transient forebrain ischemia 
 
All animal experiments were approved by the University of Pennsylvania Institutional 
Animal Care and Use Committee and were conducted according to the Guide for the 
Care and Use of Laboratory Animals. Adult male Long Evans rats were subjected to 9-
minute transient forebrain ischemia (TFI) as previously described (Neumar et al., 2001; 
Bevers et al., 2010). After anesthesia induction with isoflurane (4%), rats were then 
orotracheally intubated and mechanically ventilated with 30% O2 and 70% N2O. A 
surgical plane of anesthesia was maintained with 2.0% isoflurane. Femoral arterial and 
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venous catheters were placed and temperature was monitored with a needle thermocouple 
probe placed adjacent to the skull below the temporalis muscle. During the procedure, 
temperature was maintained between 37.0 and 37.5 °C using a warming pad and an 
overhead lamp. Electrocardiographic monitoring was performed with limb leads. TFI was 
initiated by the combination of bilateral carotid occlusion and hypovolemic hypotension 
to a mean arterial pressure (MAP) of 30 mm Hg. Hypovolemic hypotension was achieved 
by rapidly withdrawing blood from the femoral arterial catheter and was maintained 
during the ischemic period by withdrawal or infusion of blood through the femoral 
venous catheter. Once a MAP of 30 mm Hg was achieved, both carotid arteries were 
reversibly occluded with surgical aneurysm clips. After 9 minutes, the aneurysm clips 
were removed and shed blood was reinfused. Rats were maintained on mechanical 
ventilation with invasive hemodynamic monitoring for 1-hour after reperfusion. During 
this time, an intraperitoneal telemetric temperature probe (Data Systems International) 
was surgically implanted. Beginning 1-hour after reperfusion, intravenous catheters were 
removed, surgical wounds were closed, and rats were weaned from mechanical 
ventilation and extubated.  Post-injury body temperature was regulated at 36.5-38.0 
o
C 
using the intraperitoneal probe and software relays connected to a 175-W heating lamp, 
water misters and a cooling fan (Data Systems International) based on methods 
previously described (Colbourne et al., 1996; Che et al., 2011). Rats were euthanized 48-
hours post-reperfusion and both hippocampi were microdissected and processed for 
synaptosome isolation as described below. Two naïve (non-instrumented) rats were used 
as controls.  
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2.2.6. Rat model of middle cerebral arterial occlusion 
 
Adult male Sprague Dawley rats (Charles River Laboratories) were subjected to 120 
minutes focal cerebral ischemia using the filament model as described previously (Luckl 
et al., 2008). Anesthesia was induced with isoflurane (1.5% to 2.0%) in a mixture of 70% 
nitrous oxide and 30% oxygen. Each rat was intubated and placed on a mechanical 
ventilator (SAR-830P Ventilator, CWE, Ardmore, PA, USA). Body temperature was 
maintained at 37.0±0.5°C during surgery. A laser-Doppler flow (LDF) probe was placed 
over the thinned skull (4 mm lateral to midline, 1 mm posterior to Bregma) to monitor 
changes in cerebral blood flow. Through a midline neck incision, the right external and 
internal carotid arteries were dissected from the surrounding connective tissue. A 0.39 
mm silicone-coated nylon filament (Doccol Corporation, Redlands, CA, USA) was 
inserted through the right common carotid artery into the internal carotid artery to 
occlude blood flow to the middle cerebral artery (MCA) and reduce blood flow in the 
MCA territory to 20-30% of baseline. After 120 minutes of occlusion, the suture was 
withdrawn to allow for cerebral reperfusion. Rats were monitored by LDF for 30 min and 
then allowed to recover from anesthesia and euthanized either 1 or 24 hours after 
reperfusion. The ipsilateral and contralateral cortex was microdissected from the brain 
and processed for synaptosome isolation as described below.  Three animals per group 
were performed for each reperfusion time point. 
2.2.7. Isolation of synaptosomes 
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Microdissected brain regions were homogenized in 1g:10mL MSHE+BSA plus 1% 
protease inhibitor cocktail using a Dounce homogenizer. Homogenates were centrifuged 
at 1,000 g for 10 minutes at 4 
o
C. The supernatants were taken and centrifuged at 10,000 
g for 10 minutes at 4 
o
C. This pellet was resuspended in MSHE+BSA and layered above 
a 4x volume of 30% Percoll solution for gradient centrifugation at 100,000xg for 30 min 
at 4 
o
C. The synaptosome band was extracted and washed once each in MSHE+BSA and 
MSHE Buffer with centrifugation at 10,000 g for 10 minutes at 4 
o
C. Purified 
synaptosomes were resuspended and stored in MSHE Buffer.  
2.3. Results 
2.3.1. Ca
2+
-independent proteolytic activity in isolated mitochondria 
 
First, we examined the conditions required to induce ETC proteolysis in rat forebrain 
mitochondria. Based on previous studies using non-neuronal tissues, we initially 
hypothesized that ETC proteolysis was Ca
2+
-dependent (Arrington et al., 2006; 
Goudenege et al., 2007). Freeze-thawed brain mitochondria were incubated at 37 
o
C for 
60 minutes in a range of 10M-1mM CaCl2 or 1mM EGTA. Western blot was performed 
against the ETC subunits Complex V and NDUFB8 and the loading control VDAC 
(Figure 1A, left). Surprisingly, we found that addition of up to 1mM CaCl2 did not induce 
proteolysis. However, when 0.1% sodium dodecylfulfate (SDS) was added to the 
reactions, we detected proteolysis of Complex V from the 50kDa full-length to the 
30kDa fragment, as well as proteolysis of Complex I subunit NDUFB8 from the 18kDa 
full-length to the 15kDa fragment. Under these conditions, inclusion of 1mM EGTA or 
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Figure 2.1. Conditions inducing proteolysis of ETC subunits. (A) Rat brain 
mitochondria were incubated at 37 
o
C for 60 minutes in mitochondria buffer and 2mM 
BME with or without 0.1% SDS in the absence (Non-Treated) or presence of 1mM 
EGTA or 10M, 100M, or 1mM CaCl2. (B) Mitochondria were incubated at 37 
o
C 
over a time-course of 60 minutes in buffer alone (Untreated) or in the presence of 
2mM BME and 0.1% SDS. Western blots were performed using antibodies against the 
ETC subunits Complex V and NDUFB8 and loading control VDAC. 
10M-1mM CaCl2 had no effect on ETC proteolysis (Figure 1A, right). While the 
proteolytic fragments observed were consistent with mitochondrial calpain-mediated 
proteolysis, the Ca
2+
-independence of the protease was contrary to previous reports 
(Arrington et al., 2006; Goudenege et al., 2007). Analysis of these reactions generated 
from freshly isolated forebrain mitochondria provided similar results (data not shown). 
Therefore, we utilized freeze-thawed mitochondria in all subsequent experiments 
analyzing ETC proteolysis to allow for efficient storage and use of mitochondria. To 
determine the time-course of ETC proteolysis, we incubated brain mitochondria in the 
presence of 0.1% SDS for 0-60 minutes. We detected a gradual decrease in the intact and 
gradual increase in the fragment of both Complex V and NDUFB8 (Figure 1B).  
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Next, we further examined the conditions inducing ETC proteolysis in rat brain 
mitochondria to characterize the activity of the protease(s). To determine the minimum 
concentration of SDS required for ETC proteolysis, brain mitochondria were incubated in 
a range of 0-2% SDS followed by Western blot against ETC proteolytic substrates 
(Figure 2A). Proteolysis of Complex V occurred only in the presence of 0.1% or 0.2% 
SDS. Proteolysis of NDUFB8 occurred maximally at 0.02% SDS but also occurred in the 
presence of 0.1% or 0.2% SDS. Incubation of mitochondria in 2% SDS, or 0.1% SDS 
without -mercaptoethanol (BME), did not result in proteolysis of either substrate (Figure 
2A).  
Because forebrain mitochondria had not been examined in previous studies of ETC 
proteolysis, we were curious as to whether ETC subunit proteolysis could be induced in a 
similar manner in mitochondria isolated from other tissues.. Mitochondria were isolated 
from rat kidney cortex and heart, and these freeze-thawed mitochondria were incubated 
in a range of 0-2% SDS. Western blot was performed against the ETC substrates 
Complex V and NDUFB8. We found that mitochondria from rat kidney cortex 
demonstrated the same profile of SDS-induced proteolysis as rat brain mitochondria 
(Figure 2B). However, rat heart mitochondria required an order of magnitude less SDS 
for proteolysis (Figure 2C). In addition, the proteolytic fragments of both substrates were 
much less stable in heart mitochondria. Overall, it appears that ETC proteolysis can be 
induced in mitochondria isolated from different tissues in a Ca
2+
-independent manner that 
requires addition of the ionic detergent SDS and a reducing environment.  
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Figure 2.2. SDS-induced proteolysis of calpain substrates in brain, heart, and 
kidney cortex mitochondria. Freeze-thawed mitochondria isolated from adult Long 
Evans rat brain, heart, and kidney cortex were incubated at 37 
o
C for 60 minutes in the 
presence or absence of 2mM BME in a range of 0-2% SDS, followed by Western blot 
of (A) brain, (B) heart, or (C) kidney cortex samples using antibodies against Complex 
V, NDUFB8, and VDAC. 
Since we detected Ca
2+
-independent proteolytic activity that could be calpain-mediated, 
we examined the sequence homology of the rat brain calpain isoforms relative to calpain 
1 (Figure 3). We found that, in addition to lacking the Ca
2+
-binding EF-hand domains, 
calpain 10 did not possess sequence homology at the Ca
2+
-binding sites in domains II and 
III of calpain 1, which are involved in alignment of the active site of calpain 1 (yellow 
highlight) (Moldoveanu et al., 2002). However, the active site residues of calpain 10 were 
homologous with the other calpain isoforms (green highlight), suggesting that proteolytic 
activity is possible for this isoform (Figure 3). 
       D1 
calpain-1       --------MAEELITPVYCTGVSAQVQKQRDKELG-----------LGRHENAIKYLGQD 41 
calpain-2       ------------------MAGIAMKLAKDREAAEG-----------LGSHERAIKYLNQD 31 
calpain-3       MPTVISPTVAPRTGAEPRSPGPVPHPAQGKTTEAGGGHPGGIYSAIISRNFPIIGVKEKT 60 
calpain-5       ------------------------------------------------MFSCTKAYEYQN 12 
calpain-10      ------------------------------------------------------------ 
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            D2        
calpain-1       YENLRARCLQNGVLFQDDAFPPVSHSLGFKELGPNSSKTYGIKWKRPTELLSNPQFIVDG 101 
calpain-2       YETLRNECLEAGALFQDPSFPALPSSLGFKELGPYSSKTRGIEWKRPTEICADPQFIIGG 91 
calpain-3       FEQLHKKCLEKKVLYLDPEFPPDETSLFYSQKFP-----IQFVWKRPPEICENPRFIIGG 115 
calpain-5       YSALKRACLRRKVLFEDPHFPASDDSLYYKGTPG-----PTVRWKRPFDICDDPRLFVDG 67 
calpain-10      -MRAVRAETRARELFRDAAFPASDSSLFYNLSTPLAQFREDITWRRPQDICATPQLFPDN 59 
 
      C2A   A1    A2 
calpain-1       ATRTDICQGALGDCWLLAAIASLTLNETILHRVVP------YGQSFQEGYAGIFHFQLWQ 155 
calpain-2       ATRTDICQGALGDCWLLAAIASLTLNEEILARVVP------LDQSFQENYAGIFHFQFWQ 145 
calpain-3       ANRTDICQGDLGDCWLLAAIACLTLNERLLFRVIP------HDQSFTENYAGIFHFQFWR 169 
calpain-5       ISSHDLHQGQVGNCWFVAACSSLASRESLWQKVIPDWKEQEWNPEKPDSYAGIFHFNFWR 127 
calpain-10      PWEGQVKQGLLGDCWFLCACAALQKSRHLLDQVFP----PGQPGWSDQEYQGFFTCRIWQ 115 
             C2B 
calpain-1       FGEWVDVVVDDLLPTKDGKLVFVHSAQGNEFWSALLEKAYAKVNGSYEALSGGCTSEAFE 215 
calpain-2       YGEWVEVVVDDRLPTKDGELLFVHSAEGSEFWSALLEKAYAKINGCYEALSGGATTEGFE 205 
calpain-3       YGDWVDVVIDDCLPTYNNQLVFTKSNHRNEFWSALLEKAYAKLHGSYEALKGGNTTEAME 229 
calpain-5       FGEWVDVVVDDRLPTVNNQLIYCHSNSKNEFWCAPVEKAYAKLAGCYQALDGGNTADALV 187 
calpain-10      FGHWEEVTIDDRLPCLAGRLCFSRCQREDVFWLPLLEKAYAKVHGSYEHLWAGQVADALV 175 
 
calpain-1       DFTGGVTEWYDLQK--------APSDLYQIILKALERGSLLGCSINISD----------- 256 
calpain-2       DFTGGIAEWYELRK--------PPPNLFKIIQKALEKGSLLGCSIDITS----------- 246 
calpain-3       DFTGGVTEFFEIKD--------APSDMYKIMRKAIERGSLMGCSIDDGTNMTYGTSPSGL 281 
calpain-5       DFTGGVSEPIDLTEGDLATDEAKRSQLFERVLKVHSRGGLISASIKAMT----------- 236 
calpain-10      DLTGSLAERWSLKDIR------KASGQQDRPSGGEHRACQQLLRLKDQCLLS-------- 221 
                A3 
calpain-1       --------------------------------IRDLEAITFKN-----LVRGHAYSVTDA 279 
calpain-2       --------------------------------AADSEAVTYQK-----LVKGHAYSVTGA 269 
calpain-3       NMGELIARMVRNMDNSLLRDSDLDPRASDDRPSRTIVPVQYETRMACGLVKGHAYSVTGL 341 
calpain-5       --------------------------------AADMETRLACG-----LVKGHAYAVTDV 259 
calpain-10      --------------------------------CSVLSPRAGAR----ELGEFHAFIISDL 245 
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       A4 A5  C3A     C3B 
calpain-1       KQVTY--------QGQRVNLIRMRNPWGEVEWKGPWSDNSYEWNKVDPYEREQLRVKM-E 330 
calpain-2       EEVES--------SGSLQKLIRIRNPWGQVEWTGKWNDNCPSWNTVDPEVRANLTERQ-E 320 
calpain-3       EEALF--------KGEKVKLVRLRNPWGQVEWNGSWSDGWKDWSFVDKDEKARLQHQVTE 393 
calpain-5       RKVRLGHGLLAFFKSEKLDMIRLRNPWGERVWTGPWSDTSEEWQKVSKSEREKMGVTVQD 319 
calpain-10      QELRS-------QTGQGILLLRIHNPWGRRCWQGLWREGGEGWNQVEPAKESELLAQL-Q 297 
 
 C3C     D3 
calpain-1       DGEFWMSFRDFIREFTKLEICNLTPDALKSRTLRNWNTTFYE----GTWRRG-----STA 381 
calpain-2       DGEFWMSFSDFLRHYSRLEICNLTPDTLTCDSYKKWKLTKMD----GNWRRG-----STA 371 
calpain-3       DGEFWMSYDDFVYHFTKLEICNLTADALESDKLQTWTVSVNE----GRWVRG-----CSA 444 
calpain-5       DGEFWMTYEDMCRYFTDIIKCRLINTSYLS-IHKTWEEARLR----GAWTRHEDPQQNRS 374 
calpain-10      EGEFWVEEEEFLREFDEVTIGYPVTEAGHLQSLYTEKVLCHTRALPGAWVTG-----QSA 352 
 
calpain-1       GGCRNYPATFWVNPQFKIRLEEVDDADDYDSRESGCSFLLALMQKHRRRERRFG---RDM 438 
calpain-2       GGCRNYPNTFWMNPQYLIKLEEEDEDDEDGER--GCTFLVGLIQKHRRRQRKMG---EDM 426 
calpain-3       GGCRNFPDTFWTNPQYRLKLLEEDDDPDDSEV--ICSFLVALMQKNRRKDRKLG---ANL 499 
calpain-5       GGCINHKDTFFQNPQYIFEVKKPEDE-----------VLICIQQRPKRSTRREGK--GEN 421 
calpain-10      GGCRNN-SCFPCNPKFWLRLLEPSEVCVAVLQRPRRRLVGQTRALAGASPAPVNLPGKDY 411 
 
calpain-1       ETIGFAVYQVPRELAGQP-VHLKRDFFLANASRAQSEHFINLREVSNRIRLPPGEYIVVP 497 
calpain-2       HTIGFGIYEVPEELTGQTNIHLSKNFFLTTRARERSDTFINLREVLNRFKLPPGEYVLVP 486 
calpain-3       FTIGFAIYEVPKEMHGNK-QHLQKDFFLYNASKARSKTYINMREVSQRFRLPPSEYVIVP 558 
calpain-5       LAIGFDIYKVEEN---------RQYRMHSLQHKAASSIYINSRSVFLRTELPEGRYVIIP 472 
calpain-10      QAVGLHIWKVEKR-------KISLPRVLSAPPVAGTACHAYDREIHLRCELSPGYYLAVP 464 
calpain-1       STFEPNKEGDFLLRFFSEKKAGTQELDDQIQANLPDEKVLS------------------- 538 
calpain-2       STFEPHKNGDFCIRVFSEKKADYQTVDDEIEANI-EEIEAN------------------- 526 
calpain-3       STYEPHQEGEFILRVFSEKRNLSEEAENTISVDRPVKKKKNKPIIFVSDRANSNKELGVD 618 
calpain-5       TTFEPGHTGELLLRVFTDVPSNCRELR--------------------------------- 499 
calpain-10      STFLKDVPGQFLLRVFSTGKISLSAVR--------------------------------- 491 
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                    D4 
calpain-1       ----------------------------EEEIDDNFKTLFSKLAGDDMEISVKELQTILN 570 
calpain-2       ----------------------------EEDIGDGFRRLFAQLAGEDAEISAFELQTILR 558 
calpain-3       QEAEEGKDKTGPDKQGESPQPRPGHTDQESEEQQQFRNIFRQIAGDDMEICADELKNVLN 678 
calpain-5       -------------------------------LDEPPRTCWSSLCGYPQQVTQVHVLGAAG 528 
calpain-10      ---------------------------------LATKGASPGAALPAGEWETVQLQGSWR 518 
 
calpain-1       RIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRIRNYLTIFRKFDLDK 630 
calpain-2       RVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTKIQKYQKIYREIDVDR 618 
calpain-3       TVVNKHKDLKTQGFTLESCRSMIALMDTDGSGRLNLQEFHHLWKKIKAWQKIFKHYDTDH 738 
calpain-5       LKDSSTGANSYVIIKCEGEKVRSAVQRGTSTPEYNVKGIFYRKKLSQPITVQVWNNRVLK 588 
calpain-10      AGQTAGGSRNFASYPCNPCLPFSVPEGAGPRYIRITLQQHCRLSDSQLHPIGFHVFQVPA 578 
 
calpain-1       SGSMS---AYEMRMAIEAAGFKLNKKLHELIITRYSEPDLAVDFDNFVCCLVRLETMFRF 687 
calpain-2       SGTMN---SYEMRKALEEAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRLEILFKI 675 
calpain-3       SGTIN---SYEMRNAVNDAGFHLNSQLYDIITMRYADKHMNIDFDSFICCFVRLEGMFRA 795 
calpain-5       DEFLG---QVHLKTAPDDLQDLHSLHLQDRSGRQPSD----------------------- 622 
calpain-10      DGEKQDACSLLLQEPLLSCVPHCYAQEVSRLCLLSAGNYRIVPSTYLPDTEGTFTVTIAT 638 
 
calpain-1       FKILDTDLDGVVTFDLFKWLQLTMFA-- 713 
calpain-2       FKQLDPENTGTIQLDLISWLSFSVL--- 700 
calpain-3       FHAFDKDGDGIIKLNVLEWLQLTMYA-- 821 
calpain-5       -------LPGIVAVRVLCSASLTAV--- 640 
calpain-10      RIDRQSIHSQEMLGQLLQEVSFMAVMKA 666 
Figure 2.3. Sequence homology of rat brain calpain isoforms. Rattus norvegicus 
homologs of calpain 1 (NCBI Protein ID: AAH61880.1), calpain 2 (AAH65306.1), 
calpain 3 (NP_058813.1), calpain 5 (NP_604456.1), and calpain 10 
(NP_113861.1) were aligned using ClustalW 2.1 software (Larkin et al., 2007, 
http://www.ebi.ac.uk/Tools/msa/clustalw2). Sequence homology relative to calpain 
1 is marked by black highlight. Domains of calpain 1 are labeled D1-D4 and are 
separated by vertical lines. The five active site residues are in bold and highlighted 
green within the sequence and labeled A1-5 above the sequence. The Ca
2+
-binding 
sites are italicized and highlighted yellow within the sequence and labeled above 
the sequence C2A-2B for domain II and C3A-3C for domain III. 
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2.3.2. pH-dependence of ETC proteolysis 
 
Because classical calpains are known to be most active at neutral pH, we examined the 
pH-dependence of ETC proteolysis. Rat brain SMPs were resuspended in mitochondria 
buffer (pH 7.2) or 0.1M KPi, pH 6.0 or 7.2, then incubated for 60 minutes in the absence 
or presence of 0.1% SDS and 2mM BME (Figure 4). We observed that the rate of 
proteolysis of both ETC substrates was higher at pH 6.0 than pH 7.2 in 0.1M KPi, and 
that proteolysis in 0.1M KPi, pH 6.0 was greater than in our HEPES-based mitochondria 
buffer. This finding is not consistent with the activity of calpains 1, 2, or 3, which are 
most active between pH 7.0-8.2 (Shevchenko et al. 1998; Goll et al., 2003). However, the 
optimal pH values for calpains 5 and 10 have not been determined. The lower pH 
optimum could implicate an alternate cysteine protease family, the cathepsins (Grynbaum 
and Marks, 1976; Whitaker and Seyer, 
1979; Bradley and Whitaker, 1986). 
 
 
 
 
 
 
Figure 2.4. pH-dependence of ETC 
proteolysis. Rat brain mitochondria were 
incubated at 37 
o
C for 15 or 60 minutes 
in mitochondria buffer (Mito Buffer), 
0.1M KPi pH 6.0, or 0.1M KPi pH 7.2 in 
the absence or presence of 0.1% SDS and 
2mM BME. Western blot was performed 
using antibodies against Complex V, 
NDUFB8, and VDAC. 
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Figure 2.5. Effect of calpain inhibitors on ETC proteolysis. Mitochondria were 
incubated at 37 
o
C for 60 minutes in buffer alone (Untreated) or with 0.1% SDS 
and 2mM BME in the absence (Control) or presence of (A) pan-calpain 
inhibitors MDL-28170 (1, 0.1, or 0.01M), calpeptin (1, 0.1, or 0.01M), or 
calpain 10-specific inhibitor CYGAK (10, 1, or 0.1M); (B) human calpastatin 
(HCAST) peptide (10M); or (C) cathepsin B and L inhibitor Z-FF-FMK (10, 
1, 0.1, or 0.01M) or cathepsin B-specific CA-074 (1M). Western blot was 
performed using antibodies against Complex V, NDUFB8 and VDAC. 
 
2.3.3. Targeted inhibition of ETC proteolysis with calpain and cathepsin inhibitors  
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Table 2.1. IC50 values of inhibitors used in this study and effective concentrations 
blocking ETC proteolysis under the assay conditions described in Figure 2.5. 
 
Inhibitor 
 
Calpain 1 
IC50 
 
Calpain 10 
IC50 
 
Cathepsin 
L IC50 
 
Cathepsin 
B IC50 
Effective 
[inhibitor] 
blocking 
ETC 
proteolysis
a
 
MDL-28170 
Calpeptin 
CYGAK 
HCAST-P 
Z-FF-FMK 
CA-074 
10nM
b
  
6.7nM
d
  
>100uM
e
  
0.2nM
f
 
No effect
g
 
200uM
i,j
 
Unknown 
4nM
e
 
100nM
e
  
Unknown 
Unknown 
Unknown 
14.2nM
c
  
3.3nM
d
  
Unknown 
6uM
f
 
1.66nM
h
  
172uM
i
 
25nM
b
 
220nM
d
 
Unknown 
>50uM
f
 
397nM
h
 
2.24nM
i
 
100nM 
100nM 
1uM 
>10uM 
1uM 
>1uM 
a
Based on results shown in Figure 5. 
b
Mehdi 1991; 
c
Simmons et al. 2005; 
d
Sasaki et al. 1990; 
e
Rasbach et al. 2009; 
f
Pfizer et al. 2008; 
g
Parkes et al. 1985; 
h
Kang et al. 2009; 
i
Murata et al. 1991. 
j
Value for calpain 2, calpain 1 not measured. 
2008; 
g
Parkes et al. 1985; 
h
Kang et al. 2009; 
i
Murata et al. 1991. 
j
Value for calpain 2, calpain 1 not measured. To explore whether ETC proteolysis is calpain-mediated, we incubated brain SMPs in 
mitochondria buffer with pan-calpain inhibitors MDL-28170 or calpeptin plus 0.1% SDS 
(Figure 5A). Inclusion of pan-calpain inhibitors MDL-28170 and calpeptin blocked 
proteolysis at concentrations consistent with their IC50 to calpains (Figure 5, Table 1; 
Sasaki et al., 1990; Mehdi, 1991). In addition, we found that the novel calpain 10-specific 
inhibitor CYGAK also inhibited ETC proteolysis consistent with its IC50 for calpain 10 
(Figure 5A, Table 1; Rasbach et al., 2009). However, human calpastatin peptide, a potent 
inhibitor of calpain isoforms 1 and 2 (Maki et al., 1989; Pfizer et al., 2008), did not 
inhibit ETC proteolysis (Figure 5B). In addition, cathelpsin B and L inhibitor Z-FF-FMK, 
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Figure 2.6. Examination of ETC subunit proteolysis after global and focal 
ischemic brain injury. Synaptosome samples were isolated from naïve or 48-
hour post TFI (TFI) Long Evans rat hippocampus (Hipp.) and 1- or 24-hour 
post-MCAO Sprague Dawley rat contralateral (C) and ipsilateral (I) cortex. 
Western blots were performed using antibodies against the calpain-cleaved 
fragment of spectrin (Ab38), Complex V, NDUFB8, and loading control 
VDAC. As a positive control for ETC proteolysis, forebrain mitochondria 
treated with 0.1%SDS and 2mM BME for 1 hour at 37 
o
C was used (+ Control). 
but not cathepsin B-specific inhibitor CA-074, blocked ETC proteolysis (Figure 5C, 
Table 1). 
2.3.4. ETC subunit cleavage in rat brain after global and focal ischemia-reperfusion. 
 
Because calpain activity is involved in the mechanisms of neurodegeneration after global 
and focal ischemia, we hypothesized that mitochondrial calpains could become activated 
after ischemia to cleave ETC subunits, and that such proteolysis could contribute to the 
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mitochondrial dysfunction that plays a role in post-ischemic neurodegeneration. 
Therefore, we examined whether mitochondrial calpain substrates are cleaved post-
ischemia in vivo in a time-course similar to that of cytosolic calpain activity. ETC 
proteolysis was measured in purified synaptosomes because 1) it is possible that the most 
injured mitochondria may be lost during the isolation of purified mitochondria, and 2) the 
synaptosome sample is a neuron-specific compartment known to have calpain activity 
after ischemic brain injury. 
When adult rats were subjected to 9-minute transient forebrain ischemia (TFI), we 
detected the calpain-cleaved fragment of the cytosolic cytoskeletal protein -spectrin 
(Ab38) in hippocampal synaptosomes isolated 48 hours after reperfusion, but not in 
synaptosomes isolated from a naïve rat (Figure 6, lanes 2-3). We detected the cleavage 
fragment of NDUFB8, but not Complex V, in TFI-injured synaptosomes. Next, we 
subjected adult rats to 2-hour middle cerebral arterial occlusion (MCAO), followed by 1 
or 24 hours of reperfusion. Calpain-cleaved spectrin was detected at 1 hour and was 
greater at 24 hours post-reperfusion in synaptosomes isolated from the ischemic but not 
contralateral cortex. In these samples, we detected trace cleavage of NDUFB8 at 1 hour 
but not 24 hours post-reperfusion, and no proteolysis of Complex V at either time point 
(Figure 6, lanes 4-7). These results indicate that ETC proteolysis occurs to a limited 
extent after transient brain ischemia, but the time-course may be different from that of 
pathologic calpain activity in the neuronal cytosol.  
2.4. Discussion 
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Our results detecting cleavage fragments of ETC subunits NDUFB8 and Complex Vα are 
consistent with previous studies describing mitochondrial calpain activity (Arrington et 
al., 2006; Goudenege et al., 2007). We determined that previously described calpain-
mediated ETC proteolysis occurs by a Ca
2+
-independent mechanism in rat brain, heart, 
and kidney mitochondria. Comparison of the effectiveness of different calpain inhibitors 
provided additional evidence that ETC proteolysis was mediated by a cysteine protease. 
We found that the pan-calpain inhibitors MDL-28170 and calpeptin as well as the calpain 
10-specific inhibitor CYGAK blocked ETC proteolysis, but the human calpastatin 
peptide inhibitor, which blocks calpain isoforms 1 and 2, did not prevent ETC proteolysis 
(Figure 5A-B). In developing the CYGAK inhibitor, Rasbach et al. (2009) established 
that this compound inhibited calpain 10 but not calpain 1. Because calpastatin is only 
known to inhibit calpain isoforms 1 and 2 (Maki et al., 1987; Ono et al., 2004), it is 
possible that structural differences in calpain 10 may preclude its inhibition by calpasatin.  
Because MDL-28170 and calpeptin also inhibit other cysteine proteases including 
cathepsins, we tested whether Z-FF-FMK (cathepsin B/L-specific) or CA-074 (cathepsin 
B-specific) could inhibit ETC proteolysis induced by 0.1% SDS. We found that Z-FF-
FMK, blocked ETC proteolysis at a concentration consistent with its IC50 for cathepsins 
B and L (Figure 5C, Table 1; Parkes et al. 1985; Kang et al. 2009).  However, CA-074 
did not inhibit ETC proteolysis (Figure 5C, Table 1; Murata et al. 1991). 
We observed proteolysis of ETC subunits by an endogenous mitochondrial cysteine 
protease that required the presence of an ionic detergent (SDS) and a reducing agent 
(BME) (Figures 1-2). Reducing agents such as BME are routinely used to allow for 
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cysteine protease activity via reduction of the cysteine residue in the active site of the 
protease. The role of SDS detergent in the induction of proteolysis is unclear. Although 
this mechanism is not physiologic, previous in vitro studies have utilized SDS to activate 
the proteasome (Tanaka et al., 1988; Tanaka et al., 1989; Yamada et al., 1998). It is 
possible that mild SDS treatment disrupts the mitochondrial membrane or the protein 
substrates in a manner that exposes the cleavage site. This could explain the different 
SDS concentrations inducing proteolysis of the matrix substrate Complex V and the 
membrane-bound substrate NDUFB8 (Figure 2). Alternatively, mild SDS treatment may 
alter the conformation of the protease to initiate proteolytic activity. It appears that 
treatment with a higher concentration of SDS fully denatured either the protease or the 
substrates, preventing ETC proteolysis. We also observed that incubation of mitochondria 
at 25 
o
C rather than 37 
o
C increased the SDS required for ETC proteolysis (data not 
shown). This is likely due to the decreased lability of proteins and lipid membranes at 
lower temperature. It was surprising that an order of magnitude less SDS was required to 
induce proteolysis in heart mitochondria compared to brain and kidney cortex 
mitochondria (Figure 2). This result could be due to the level of expression of the 
protease in each tissue, or it could reflect differences in the structure of mitochondria 
isolated from each tissue.  
Our finding that ETC proteolysis was Ca
2+
-independent was inconsistent with the well-
defined, Ca
2+
-dependent activity of classical calpains. In addition to the C-terminal Ca
2+
-
binding domain IV, calpains 1, 2, 3, and 5 contain highly conserved Ca
2+
-binding motifs 
in domains II and III that serve to align the active site of these proteases when in the 
43 
 
Ca
2+
-bound state (Moldoveanu et al., 2002; Suzuki et al., 2004). Based on sequence 
homology of these isoforms from the rat, calpains 5 and 10 lack the C-terminal domain 
IV. In addition, calpain 10 lacks both Ca
2+
-binding motifs in domains II and III (Figure 3; 
Moldoveanu et al., 2002). Similar results have been reported regarding calpain isoforms 
of human origin (Sorimachi and Suzuki, 2001; Suzuki et al., 2004). Studies reporting 
Ca
2+
-dependent proteolysis by calpain 10 did not directly examine the isolated enzyme 
(Marshall et al., 2005; Arrington et al., 2006; Giguere et al., 2008; Rasbach et al., 2009). 
In fact, proteolytic or autolytic activity of isolated or recombinant calpain 10 was not 
detected when incubated in 5mM Ca
2+
 under conditions that activated calpains 1 and 2 
(Dong and Liu, 2008). Therefore, the Ca
2+
-dependence of calpain 10 is not certain, and 
the physiologic mechanism of activation of this protease remains to be discovered. 
Interestingly, we found that ETC proteolysis was greater at pH 6.0 than at pH 7.2 (Figure 
4). Calpains 1, 2, and 3 are most active at neutral pH, but the optimal pH of calpains 5 
and 10 are unknown. Another family of cysteine proteases, cathepsins, is typically more 
active at lower pH. We are not aware of any published reports of cathepsin protein 
expression in mitochondria under physiologic conditions. Although Kosenko et al. (2010) 
provided evidence of cathepsin B and D enzyme activity in hippocampal mitochondria 
that is increased after chronic treatment with amyloid β-protein, cathepsin release from 
lysosomes has been reported in Alzheimer’s disease models (Nakamura et al., 1991). 
Taken together, our results characterizing ETC subunit proteolysis are most consistent 
with the reported activity of calpain 10. However, the potential involvement of a different 
endogenous mitochondrial cysteine protease cannot be ruled out.  
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Although there are other well-known classes of endogenous mitochondrial proteases, it is 
unlikely that they are the cause of ETC subunit proteolysis measured in this study. The 
mitochondrial processing peptidase, mitochondrial intermediate peptidase, and inner 
membrane peptidase act together to cleave mitochondrial localization sequences from 
successfully targeted proteins (Koppen and Langer, 2007). The matrix- and 
intermembrane space-facing ATPase associated with diverse cellular activities proteases, 
caseinolytic peptidase, and Lon protease are responsible for degradation of damaged or 
misfolded mitochondrial proteins, including ETC subunits, and are critical for prevention 
of neurodegeneration under oxidative stress conditions (Haynes et al., 2007; Ugarte et al., 
2010; Martinelli and Rugarli, 2010). Omi and the presenilins-associated rhomboid-like 
protein are two other serine proteases located in the intermembrane space, but their 
endogenous substrates are unknown (Martinelli and Rugarli, 2010). However, none of 
these proteases are in the cysteine protease family, and they would not be inhibited by the 
protease inhibitors used in this study. 
The importance of the mitochondrial calpain system pathology has been magnified by 
numerous recent studies correlating polymorphisms in the calpain 10 gene in the 
susceptibility to type 2 diabetes mellitus (Horikawa et al., 2000; Horikawa, 2006). We 
hypothesized that calpain-mediated proteolysis of ETC subunits might play a role in 
mitochondrial dysfunction caused by global and focal brain ischemia. When adult rats 
were subjected to TFI and MCAO, we observed calpain-mediated proteolysis of spectrin 
in synaptosomes in a time-course correlating with neuronal cytosolic Ca
2+
-overload and 
delayed neurodegeneration, consistent with previous results (Saido et al., 1993; Roberts-
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Lewis et al., 1994; Neumar et al., 1996; Bartus et al., 1998; Neumar et al., 2001). We did 
not detect proteolysis of Complex V in synaptosomes after TFI or MCAO. However, 
we could detect low levels of NDUFB8 cleavage fragment 48-hours after TFI and 1-hour 
but not 24-hours after MCAO (Figure 6). Based on the accumulation of spectrin and 
NDUFB8 cleavage products, it appears that the time-course of ETC proteolysis after 
MCAO was different from the time-course of cytosolic Ca
2+
-overload and calpain 
activity. Therefore, the mechanism of activation of ETC proteolysis after ischemic brain 
injury remains to be determined, but it appears to be independent of [Ca
2+
]m. We cannot 
speculate on the functional consequence of the low level of NDUFB8 proteolysis 
observed in our in vivo models. However, our results indicate that this ETC subunit is 
cleaved under pathologic conditions in vivo.   
In summary, our results provide evidence for Ca
2+
-independent proteolysis of select ETC 
subunits. ETC proteolysis had characteristics consistent with the activity of calpain 10. In 
addition, we detected a similar pattern of proteolysis of NDUFB8 in vivo after both focal 
and global transient brain ischemia. Moving forward, it will be important to definitively 
identify the protease causing ETC subunit proteolysis and determine its role in 
mitochondrial dysfunction after ischemia-reperfusion and in other pathologies involving 
disrupted mitochondrial homeostasis. 
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EFFECT OF CALPAIN SMALL SUBUNIT 1 KNOCKDOWN ON CALPAIN 
ACTIVITY AND NEURODEGENERATION IN CEREBELLAR PURKINJE 
CELLS AFTER CARDIAC ARREST 
 
3.1. Introduction 
 
Calpains are a family of Ca
2+
-dependent neutral cysteine proteases involved with many 
critical cellular functions such as cell division and long-term potentiation (reviewed in 
Goll et al., 2003). Pathologic calpain activity has been associated with neurodegeneration 
in numerous models of acute and chronic neurodegeneration, including global and focal 
ischemia (Neumar et al., 2001; Markgraf et al., 1998), traumatic brain and axonal injury 
(Schoch et al., 2012; Ma et al., 2012), Alzheimer’s disease (Higuchi et al., 2012; Ferreira 
and Bigio, 2011), and Parkinson’s disease (Vosler et al., 2008). 
Previous studies by our laboratory and others have determined that calpain activity is 
necessary for neurodegeneration of hippocampal CA1 pyramidal neurons after global 
ischemia (Li et al., 1998; Cao et al., 2007; Bevers et al., 2010). The classical calpains, 
isoforms 1 and 2, share a regulatory subunit calpain small subunit 1 (capns1), and we 
have shown targeted knockdown of calpain-1, but not calpain-2, prevents post-ischemic 
neurodegeneration in the hippocampus (Bevers et al., 2010). The role of calpain activity 
in cerebellar neurodegeneration after global ischemia has not been explored, in part 
because models of global ischemia targeting the forebrain do not injure the hippocampus, 
and therefore a whole-body cardiac arrest model is required. Purkinje cells of the 
cerebellum are a selectively vulnerable neuron population that degenerates after cardiac 
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arrest in human patients and animal models (Horn an Schlote, 1992; Ng et al., 1989; 
Welsh et al., 2002).  
The currently available evidence suggests that Purkinje cells degenerate via a Ca
2+
-
mediated pathway (Yamashita et al., 2006; Brasko et al., 1995; Zhao et al., 2008). In a 
high-[Ca
2+
] environment, calpains cleave a variety of intracellular substrates in a targeted 
fashion to inactivate the substrate, or in some cases create a gain of function of one or 
both proteolytic fragments. Many of these substrates are Ca
2+
-regulatory proteins, and 
their cleavage by calpain is thought to create a feed-forward system of intracellular Ca
2+
 
entry, which induces a non-apoptotic cell death (reviewed in Bevers et al., 2008). 
Therefore, we hypothesized that inhibition of calpain activity would prevent 
neurodegeneration of Purkinje cells in the cerebellum after cardiac arrest. Because 
mRNA expression of calpain-2 is much greater than calpain-1 in cerebellar Purkinje cells 
than in hippocampal CA1 pyramidal neurons (Li et al., 1996), we chose to knock down 
functional activity of both the calpain-1 and calpain-2 catalytic subunits using an RNA 
interference approach targeting the common regulatory subunit capns1. We transduced 
cerebellar Purkinje cells in vivo with adeno-associated viral (AAV) vectors expressing 
short hairpin RNA (shRNA) corresponding to capns1 or a scramble control sequence and 
measured the effect of functional calpain knockdown on neurodegeneration 48 hours 
after cardiac arrest. 
3.2. Materials and Methods 
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3.2.1. Primary hippocampal neuron culture 
 
Primary hippocampal neurons were cultured as described previously (Bevers et al., 
2009).  Neurons from the hippocampus of E19 Sprague-Dawley rat embryos were plated 
at a density of 100,000 cells/mL in 24-well plates with glass coverslips 
(immunofluorescence) or 400,000 cells/mL in 35mm Petri dishes (mRNA or protein 
lysates) pre-treated with poly-L-lysine in serum-free Neurobasal media with B27 
supplement (Gibco). Neurons were incubated at 37 
o
C in 5% CO2. At seven days in vitro 
(DIV), neurons were transduced with 1.0 x 10
11
 genome copies (GC) of adeno-associated 
virus (AAV2/9.hU6.shRcapns1.CB7.mCherry or AAV2/9.hU6.scr.CB7.mCherry, 
produced by the University of Pennsylvania Vector Core Facility). All appropriate 
biosafety procedures were followed in handling the AAV vectors, which are rated BSL-1 
and have never been shown to cause human pathology. Neurons were harvested at 21 
DIV, or two weeks post-transduction. 
3.2.2. mRNA harvest and rtPCR  
 
Total RNA lysates were obtained using Trizol (Invitrogen) and purified using an RNeasy 
Mini Kit (Qiagen), as described previously (Bevers et al., 2009). To generate cDNA, 
250ng RNA lysates were incubated in OligoDT primer (Invitrogen) and Superscript II 
reverse transcriptase (Invitrogen). 
3.2.3. Western blot 
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Western blot was performed as previously described (Bevers et al., 2009). Molecular 
weights were estimated using Precision Plus Protein Kaleidoscope Standards (Bio-Rad). 
Primary antibodies used were anti calpain small subunit 1 clone m-80a (a generous gift 
from Peter Greer), anti-actin clone AC-40 (Sigma), and anti-calpain-cleaved spectrin 
clone Ab38 (provided by Robert Siman). Horseradish peroxidase-linked goat anti-mouse 
and anti-rabbit (PerkinElmer) secondary antibodies were used. Western blots were 
visualized using enhanced chemiluminescence solution (PerkinElmer). 
3.2.4. Viral vector injection in rat cerebellum 
 
Viral vector injections were performed on rats between 325-425g. A surgical plane of 
anesthesia was maintained using inspired 2% isoflurane with 66% nitrous oxide and 33% 
oxygen. A 2.0L volume of AAV2/9.hU6.shRcapns1.CB7.mCherry or 
AAV2/9.hU6.scr.CB7.mCherry viral vector at a concentration of 5.0 x 10
12
 genome 
copies (GC)/mL (1.0 x 10
10
 total GC) was injected into the primary fissure of the 
cerebellum at the midline (coordinates -11.5mm caudal, 0.0mm lateral to Bregma, depth 
of 2.8mm) using a rodent stereotax (ASI Instruments) and microinjector pump (World 
Precision Instruments) with a 25L glass microsyringe (Hamilton). Rats were allowed to 
recover for two weeks prior to cardiac arrest to allow for vector expression and protein 
knockdown. 
3.2.5. Rat model of cardiac arrest 
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This study was approved by the University of Pennsylvania Institutional Animal Care and 
Use Committee (Philadelphia, PA). Adult male Long Evans rats, 350-450g, were 
subjected to cardiac arrest as previously described, with some modifications (Che et al., 
2010). Briefly, rats were orotracheally intubated and maintained under anesthesia using 
2% isoflurane with 66% nitrous oxide and 33% oxygen. Temperature, measured using a 
needle thermocouple probe placed between the temporalis muscle and the skull, was 
monitored and maintained between 37.0 and 37.5 
o
C  until the time of cardiac arrest. 
Asphyxial cardiac arrest was induced by cessation of mechanical ventilation after 
neuromuscular blockade.  After seven minutes asphyxia, mechanical ventilation was 
resumed, intravenous epinephrine (0.005 mg/kg) and bicarbonate (1.0 mEq/kg) were 
administered, and external chest compressions were performed at a rate of 350–400 
compressions/min until return of spontaneous circulation (ROSC). Inspired oxygen was 
then restored to achieve a pulse oximetry reading between 94% and 98%. One hour after 
ROSC, rats were weaned from mechanical ventilation. An intraperitoneal temperature 
probe was inserted, and rats were transferred to a specialized temperature regulation 
cubicle for extended temperature monitoring and maintenance in the normothermic range 
(37°C  1°C) for 48 hours after ROSC, at which time rats were transcardially perfused 
using 4% paraformaldehyde. 
3.2.6. Histologic staining with FluoroJade B 
 
Histology was performed similar to Siman et al. (2005).  Sagittal 20m sections of the 
medial 600m of the cerebellar vermis were generated using a freezing-sliding 
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microtome (Microm). Every tenth section, randomized to the first section—a total of five 
sections per cerebellum—was mounted on glass slides and incubated for 10 minutes in 
0.06% potassium permanganate, followed by 20 minutes in 0.004% FluoroJade 
B(Millipore) in solution of 0.1% acetic acid.  Slides were coverslipped with DPX 
mounting media (Fluka). 
3.2.7. Real-time polymerase chain reaction (rtPCR) 
 
Quantitative rtPCR was performed using the fluorescent indicator SYBR Green (Applied 
Biosystems) and primers unique to the sequence of capns1 (Integrated DNA 
Technologies) on a MX3000P PCR cycler (Stratagene). The median of triplicate samples 
was chosen for three samples per condition per trial. The number of cycles to half-
maximal SYBR Green fluorescence was corrected for each sample using the 
housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT). A total of 
three trials were performed, and all samples were averaged by treatment group, then 
normalized to naïve. 
3.2.8. Immunofluorescence 
 
Immunocytochemistry of primary hippocampal neurons using primary antibodies anti-
MAP2 clone AP14 (a gift from Dr. Virginia Lee, University of Pennsylvania) and anti-
capns1 clone m80-a (a gift from Dr. Peter Greer, Queens University) were performed 
using goat anti-mouse Alexa 568 and goat anti-rabbit Alexa 488 secondary antibodies 
(Invitrogen), respectively, as described previously (Bevers et al., 2009). 
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Immunofluorescence of 20m sagittal sections of the cerebellar vermis was performed 
using a primary antibody specific to the calpain-cleaved fragment of spectrin (a gift from 
Dr. Robert Siman, University of Pennsylvania) and secondary antibody goat anti-rabbit 
Alexa 488, as described (Bevers et al., 2010). 
3.2.9. Semiquantitative analysis of calpain-cleaved spectrin 
 
We quantified mean fluorescence intensity of transduced and non-transduced regions of 
the primary fissure from every 10
th
 section of the cerebellar vermis (4-5 sections per 
cerebellum) from sham- or cardiac arrest-injured rats one hour post-ROSC. Backgound 
fluorescence intensity was calculated as the mean fluorescence intensity in Lobule X, and 
was corrected for each section.  
3.2.10. Statistical analysis 
 
Comparison of capns1 mRNA and protein expression in primary hippocampal neurons 
transduced with shR-capns1 or scr AAV vector or naïve control was performed using 
one-way analysis of variance (ANOVA) with Bonferonni post-hoc analysis for 
significance (Stata). For calpain-cleaved spectrin immunoreactivity, we compared 
corrected mean fluorescence intensity in transduced vs. non-transduced primary fissure 
subjected to cardiac arrest injury or sham using one-way ANOVA with Bonferonni 
analysis. To compare the quantity of FluoroJade-labeled degenerating Purkinje cells in 
the primary fissure of shR-capns1 vs. scr-transduced cerebellum, average FluoroJade
+
 
cell counts per section were compared using one-tailed Student’s t Test. 
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Figure 3.1. Design of AAV2/9 shRNA 
vector targeting Capns1 or scramble. (A-
B) Expression of scramble (scr) or shR-
capns1 is driven by the human U6 promoter 
(hU6), and mCherry is driven by the CB7 
promoter. (C) Capns1 shRNA sequence. 
3.3. Results 
 
3.3.1. Design and validation of AAV2/9 
vector expressing capns1 shRNA. 
 
In order to determine the role of calpain 
activity in cerebellar Purkinje cell 
degeneration after cardiac arrest, we 
implemented a vector-mediated approach 
to functionally knock down calpain-1 and 
calpain-2 catalytic activity. We designed short hairpin RNA targeting the regulatory 
calpain subunit capns1, as heterodimerization of this regulatory subunit is required for 
activity of the catalytic isoforms calpain 1 or 2. AAV plasmids were constructed co-
expressing shRNA targeting capns1 (shR-capns1) or a scramble control sequence 
(scramble) driven by the human U6 promoter (hU6) and the red fluorescent marker 
protein mCherry driven by the chicken β-actin promoter with cytomegalovirus enhancer 
(CB7) (Figure 1A). These plasmids were packaged into AAV2/9 viral vectors for neuron 
transduction. Expression and targeted knockdown was validated in primary hippocampal 
neurons transduced with each vector. Neurons were transduced at 7 days in vitro and two 
weeks later were harvested for protein or RNA lysates. Expression of capns1 mRNA 
relative to the housekeeping gene HPRT was compared between naïve 
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Figure 3.2. Expression of AAV2/9 shR-capns1 vector and target knockdown. 
Primary hippocampal neurons transduced with 1.5 x 10
11
 GC AAV2/9 viral vector 
were harvested two weeks later. A: Relative normalized mRNA expression level 
quantified by rtPCR. *p<0.001. B. Western blot of naïve, scr, or shR-capns1 
transduced neuronal lysates for Capns1 and actin. C: Densitometry of Western blot 
represented in B. *p<0.01. D-K:Immunocytochemistry of Scr-transduced (D-G) or 
shR-capns1-transduced (H-K) neurons against MAP2 (blue, D,H) and Capns1 
(green, E-I), mCherry fluorescence (red, F-J), and merge (G-K). 
and transduced neurons. As shown in Figure 2B, AAV2/9.U6.shR-capns1.CB7.mCherry 
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transduction reduced capns1 mRNA levels compared to naïve and 
AAV2/9.U6.scr.CB7.mCherry transduced neurons (p<0.01). In addition, significant 
Capns1 protein knockdown in shR-capns1-transduced neurons was verified by Western 
blot, using an antibody specific to Capns1 and quantified by densitometry relative to the 
 
Figure 3.3. Effect of capns1 knockdown on calpain activity 1-hour post-ROSC. Two 
weeks after intracerebellar injection of AAV2/9 viral vector expressing scr control (A-
C) or shR-capns1 (D-F), rats were subjected to cardiac arrest followed by 1-hour 
reperfusion. Representative images of region of transduced (T) and non-transduced 
(N) regions of primary fissure depicting mCherry fluorescence (A,D), calpain-cleaved 
spectrin immunoreactivity (B,E), and merge (C,F).  
57 
 
 
Figure 3.4. No calpain activity in transduced neurons from sham-injured controls. 
Two weeks after intracerebellar injection of AAV2/9 vector expressing scr control (A-
C) or shR-capns1 (D-F), rats were subjected to cardiac arrest and 1-hour reperfusion. 
Representative images of transduced regions of primary fissure depicting mCherry 
fluorescence (A,D), calpain-cleaved spectrin immunoreactivity (B,E) and merge (C,F). 
loading control actin (Figure 2C-D). 
3.3.2. Vector-mediated knockdown of calpain activity after cardiac arrest in rat 
cerebellum 
 
Next, we tested whether expression of the shR-capns1 vector in vivo would block calpain 
activity after cardiac arrest. Intracerebellar injections into the primary fissure at the 
midline were performed with either AAV2/9.U6.shR-capns1.CB7.mCherry or 
AAV2/9.U6.shR-scr.CB7.mCherry in adult rats. Two weeks post-injection, rats were 
subjected to 7-minute cardiac arrest followed by cardiopulmonary resuscitation. One hour 
after ROSC, cerebella were processed for immunofluorescence labeling using an 
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Figure 3.5. No detectable calpain 
activity in Lobule X 1-hour after 
ROSC. Representative images of 
calpain-cleaved spectrin immuno-
labeling in cerebellar sections from 
rats subjected to sham (A) or cardiac 
arrest injury and 1-hour reperfusion 
(B). Calpain-cleaved spectrin 
immunoreactivity is not detectable in 
Lobule X, but is clearly detectable in 
Lobule IX 1-hour post-ROSC. 
 
Figure 3.6. Capns1 knockdown 
significantly reduces calpain activity 1-
hour after ROSC. Semiquantitative 
analysis was performed on calpain-
cleaved spectrin immunofluorescence in 
transduced and non-transduced regions 
of primary fissure from rats subjected to 
sham or cardiac arrest injury one hour 
after ROSC. *p<0.05. 
antibody specific to calpain-cleaved spectrin. As expected, we found that Purkinje cells in 
the primary fissure transduced with shR-capns1 (fluorescing red due to expression of 
mCherry) had decreased calpain activity compared to the non-transduced region of the 
primary fissure (Figure 3A-C). Alternatively, expression of scramble vector appeared to 
have no effect on calpain activity (Figure 3D-F). The intensity of calpain-cleaved spectrin 
was analyzed semiquantitatively, and as expected, calpain activity in the region of shR-
capns1-transduced Purkinje cells was significantly decreased compared to non-
transduced and scramble-transduced Purkinje cells (p<0.01) (Figure 3G). 
3.3.3. Effect of capns1 knockdown on neurodegeneration after cardiac arrest  
 
To determine the role of calpain activity on Purkinje cell degeneration after cardiac 
arrest, rats were injected with shR-capns1 or scr AAV2/9 viral vector into the cerebellum 
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Figure 3.7. FluoroJade stain of cerebellar primary fissure 48-hours post-ROSC. 
Two weeks post-injection with AAV2/9 scr or shR-capns1 vector, rats were subjected 
to cardiac arrest injury. At 48 hours post-ROSC, cerebellar sections were stained with 
FluoroJade. A-C: scr-transduced region of primary fissure stained with FluoroJade 
(green, A), mCherry fluorescence (red, B), and merge (C). Arrows denote Fluorojade-
labeled Purkinje cells absent mCherry co-labeling. D-E: representative regions of scr 
(D) and shR-capns1 (E) primary fissure stained with FluoroJade. 
as described above. Two weeks post-injection, rats were subjected to cardiac arrest and 
allowed to recover for 48 hours after reperfusion. Serial cerebellar sections were stained 
using FluoroJade, an anionic dye that stains degenerating neurons. Unexpectedly, we 
found that FluoroJade-labeling cells in the Purkinje layer did not co-label with the 
mCherry expression marker in the transduced region (Figure 3A-C, scr-transduced 
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section shown). One potential cause of this result would be that the mCherry protein 
leaked out of the degenerating cells. Therefore, we quantified the number of FluoroJade-
labeled Purkinje cells in the transduced region of the cerebellum—the primary fissure at 
the midline—disregarding co-labeling with mCherry. We detected an average of 44  27 
cells in the primary fissure of shR-capns1-transduced cerebellar sections and an average 
of 35  23 cells in the primary fissure of scr-transduced cerebellar sections. Therefore, we 
have no evidence that knockdown of calpain activity in cerebellar Purkinje cells blocks 
neurodegeneration after cardiac arrest. 
 
3.4. Discussion 
 
As expected, expression of shRNA targeting the calpain regulatory subunit capns1 
resulted in a significant reduction in transcript and protein expression (Figure 1). In 
addition, targeted knockdown of capns1 significantly reduced calpain activity one-hour 
post-ROSC (Figure 2). However, our attempt to quantify the effect of capns1 knockdown 
on neurodegeneration 48 hours after ROSC was confounded by the lack of mCherry 
signal in degenerating neurons labeling with FluoroJade (Figure 3A-C). This was 
presumably due to the marker protein leaking out of the degenerating cells. Therefore, we 
took an alternative approach to quantify the number of degenerating cells in the primary 
fissure irrespective of mCherry co-labeling to get an indication of the effect of capns1 
knockdown (Figure 3D-E). However, the scr-transduced and shR-capns1-transduced 
primary fissure had a comparable number of degenerating cells, which is not indicative of 
a neuroprotective effect of capns1 knockdown in Purkinje cells after cardiac arrest. 
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There are a number of caveats to our result that might have prevented us from detecting a 
protective effect of calpain inhibition in our model.  As stated above, we could not 
specifically compare populations of Purkinje cells transduced with shR-capns1 vs. scr 
viral vector, presenting a challenge to discerning significant differences. In addition, the 
level of calpain knockdown was not quantified in vivo and is unlikely to approach 100%. 
Although we found robust knockdown in calpain activity 1 hour after cardiac arrest, the 
residual capns1 could be enough to execute its neurodegenerative function over the 
course of 48 hours. Finally, our observation contained only a single time point, and 
human data suggests that post-cardiac arrest neurodegeneration in the cerebellum is a 
process that occurs over days and weeks (Horn and Schlote, 1992). It is possible that 
quantification of surviving neurons one to two weeks post-injury could provide a more 
reliable measure of injury magnitude. 
If calpain activity does not play a critical role in Purkinje cell degeneration after cardiac 
arrest, this would differ from the mechanism of cell death of hippocampal CA1 pyramidal 
neurons. The time-course of degeneration is slightly accelerated in the cerebellum 
compared to the hippocampus, with maximal FluoroJade labeling at 48-hours post-injury 
in the cerebellum and at 72-hours post-injury in the hippocampus (unpublished 
observations). This phenomenon could be explained by the activation of alternative cell 
death mechanisms, such as activity of the caspase or cathepsin family of proteases or 
other cell death signaling events, such as mitochondrial permeability transition or release 
of apoptosis inducing factor (Ofeingeim et al., 2012; Yamashima and Oikawa, 2009; 
Friberg and Wieloch, 2002; Wang et al., 2009). In addition, Purkinje cells may be more 
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susceptible to excitotoxic injury due to the magnitude of synaptic input to the Purkinje 
circuit by the inferior olive (Welsh et al. 2002). Expression of channels that alleviate Ca
2+
 
overload, including the glutamate aspartate transporter (GLAST) and excitatory amino 
acid receptor-4 (EAAT4), has been shown to prevent Purkinje cell death after global 
ischemia (Yamashita et al., 2006). Further exploration of these mechanisms could yield 
an interesting contrast with the mechanisms of neurodegeneration in the hippocampus. In 
conclusion, our results reiterate that it is critical to examine multiple brain regions to 
develop maximally protective therapeutic strategies in complex injury models such as 
cardiac arrest. 
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CEREBELLAR PURKINJE CELL NEURODEGENERATION 
AFTER CARDIAC ARREST: EFFECT OF THERAPEUTIC 
HYPOTHERMIA 
 
4.1. Introduction 
Cardiac arrest is the most common cause of reversible global brain ischaemia (Nichol et 
al., 2008). Of those who are resuscitated after out-of-hospital cardiac arrest and admitted 
to the hospital, brain injury is the most common cause of death, and up to half of patients 
surviving to hospital discharge display significant neurologic dysfunction (Laver et al., 
2004; Aufderheide et al., 2011; Stiell  et al., 2011). Currently, induced therapeutic 
hypothermia (TH) is the only therapy proven in prospective randomized clinical trials to 
improve survival and neurologic outcome of comatose cardiac arrest survivors 
(Hypothermia After Cardiac Arrest Study Group, 2002; Bernard et al., 2002). In animal 
models, the neuroprotective effect of prolonged post-cardiac arrest TH has been 
demonstrated for hippocampal CA1 pyramidal neurons (Hicks et al., 2000; Katz et al., 
2004; Che et al., 2011). However, little is known about its effect on other selectively 
vulnerable neuron populations.  
Next to hippocampal CA1 pyramidal neurons, cerebellar Purkinje cells are among the 
most vulnerable to injury caused by cardiac arrest (Ng et al., 1989; Horn and Schlote, 
1992). Loss of Purkinje cells after cardiac arrest could contribute to neurologic 
dysfunction, including post-hypoxic myoclonus (Welsh et al., 2002; Sarna and Hawkes, 
2003; Venkatesan and Frucht, 2006). As in other selectively vulnerable regions, Purkinje 
cell neurodegeneration is thought to be caused by excitotoxicity (Brasko et al., 1995; 
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Yamashita et al., 2006; Zhao  et al., 2008). Additionally, Purkinje cell degeneration is 
delayed after cardiac arrest, beginning at 2-3 days in animal studies and 4 days in humans 
(Sato et al., 1990; Horn and Schlote, 1992; Welsh et al., 2002). This delayed 
neurodegeneration presents a potential therapeutic window after return of spontaneous 
circulation (ROSC) to protect neurons from ischaemic injury and potentially alleviate 
neurologic deficits.  A previous study reported that permissive post-cardiac arrest 
hypothermia compared to controlled normothermia resulted in decreased neuronal injury 
at 72 hours in multiple brain regions including the cerebellum based on semiquantitative 
analysis (Hickey et al., 2000). To our knowledge, there are no published studies that have 
quantitatively examined the effect of induced post-cardiac arrest hypothermia on Purkinje 
cell survival. 
A persistent concern related to the implementation of post-cardiac arrest TH is optimizing 
onset and duration of therapy to maximize neuroprotective effect. Our laboratory recently 
reported that post-cardiac arrest TH initiated at 0, 1, 4, or 8 hours after cardiac arrest 
resulted in comparable protection of hippocampal CA1 pyramidal neurons, while TH 
maintained for 48 hours resulted in significantly greater neuroprotection compared to TH 
maintained for 24 hours (Che et al., 2011). To examine the effect of post-cardiac arrest 
TH onset and duration on cerebellar Purkinje cell survival, we now report the analysis of 
cerebella from these same animals.  
4.2. Materials and methods 
4.2.1. Rat Model of Asphyxial Cardiac Arrest 
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This study was approved by the University of Pennsylvania Institutional Animal Care and 
Use Committee (Philadelphia, PA).  Detailed methods and results regarding temperature 
regulation, haemodynamic parameters, survival, neurologic function, and hippocamapal 
CA1 pyramidal neuron survival have been published (Che et al., 2011). The injury model 
is described briefly here. Adult male Long Evans rats (325-375g, Harlan Laboratories, 
Indianapolis, IN) were initially anesthetized with 4% isoflurane, 66% nitrous oxide, and 
33% oxygen, and maintained with 2% isoflurane after orotracheal intubation.  
Mechanical ventilation was performed using a pressure-controlled ventilator (Kent 
Scientific, Torrington, CT). Temperature was monitored during the peri-arrest period 
with a needle thermocouple probe placed between the temporalis muscle and the skull, 
and temperature was maintained between 37.0 and 37.5 
o
C up to the time of asphyxia. 
Asphyxial cardiac arrest was induced by cessation of mechanical ventilation after 
neuromuscular blockade. After ten minutes asphyxia, mechanical ventilation was 
resumed, intravenous adrenaline (epinephrine, 0.005 mg/kg) and bicarbonate (1.0 
mEq/kg) were administered, and external chest compressions were performed at a rate of 
350–400 compressions/min until ROSC. Following ROSC, inspired oxygen was restored 
to maintain a pulse oximetry reading of 94% to 98%. One hour after ROSC, a telemetric 
temperature probe was inserted into the peritoneum for post-surgical temperature 
regulation. After weaning from mechanical ventilation, rats were transferred to a 
specialized temperature regulation cubicle.  Immediately after ROSC, rats were block 
randomized to normothermia (37°C  1°C) or TH (33°C  1°C) initiated 0, 1, 4, or 8 
hours after ROSC and maintained for 24 or 48 hours (eight groups, n=21 per group; 
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seven-day survivors shown in Table 1). Sham injured rats underwent surgical 
instrumentation under general anesthesia without asphyxiation or cardiopulmonary 
resuscitation (n = 6; Table 1). 
4.2.2. Immunohistochemistry 
 
Rats surviving seven days were transcardially perfused with 4% paraformaldehyde. 
Brains were post-fixed and processed as previously described (Che et al., 2012). Sagittal 
50m sections of the cerebellum were generated using a freezing sliding microtome 
(Microm HM 440E, Walldorf, GER) and stored in cryoprotectant solution (30% glycerol, 
30% sucrose in 1M phosphate buffered saline, pH 7.2). 
Every tenth section from the medial 2.5mm of the cerebellar vermis was selected with 
randomization of the first section. Sections were incubated in 30% methanol/0.5% H2O2 
for 20 minutes to inactivate endogenous peroxidases. Purkinje cells were immunolabeled 
using an antibody to calbindin (AB1778, Millipore). Secondary antibody, biotinylated 
goat anti-rabbit (BA-1000, Vector Labs) was applied, followed by incubation in avidin-
biotin-horseradish peroxidase solution (ABC Kit PK-6101, Vector Labs). Sections were 
treated with 0.4mg/mL 2,4-diaminobutyric acid (D5905, Sigma) for 5-8 minutes. 
Sections were mounted and coverslipped using DPX (44581, Sigma). 
4.2.3. Thionin Stain and Quantification of Purkinje Cells 
 
Every tenth section from the medial 2.5mm of the cerebellar vermis was selected with 
randomization of the first section. Nissl stain was performed on mounted slides according 
67 
 
to Gerfen (2003), with some modifications. Slides were incubated in thionin solution 
(2.5mg/mL thionin (861340, Sigma), 14.4mg/mL NaOH, 1.2% acetic acid in ddH2O) for 
1 minute, then rinsed once with ddH2O and incubated for 2 minutes in ddH2O. Slides 
were incubated for two minutes in a series of 70%, 80%, 95%, and 100% (twice) ethanol. 
If additional destaining was required, slides were incubated for two minutes in 95% 
ethanol/1% acetic acid followed by two two-minute washes with 100% ethanol.  Slides 
were cleared with xylene and coverslipped with DPX. 
Quantification of Purkinje cell density in the primary fissure and Lobule X was 
performed using an approach similar to Lu et al. (2008). Photomontages of light 
microscopic images from each cerebellar region were generated using Photoshop 
Elements 7.0 (Adobe). Purkinje cells were identified as large, rounded cell bodies in the 
Purkinje layer, between the granule and molecular layers. Degenerating Purkinje cell 
bodies, indicated by a darkened and shrunken morphology, were excluded from counting. 
Purkinje cells were counted and the length of the cerebellum region analyzed was 
measured using ImageJ (National Institutes of Health). Total Purkinje cell counts were 
divided by total length measured to calculate Purkinje cell density for each animal. All 
values are reported as mean  standard deviation. 
4.2.4. Statistical Analysis 
 
For statistical comparison of group means of Purkinje cell density in the primary fissure, 
one-way analysis of variance was performed with Bonferonni analysis for significance 
(Stata). For comparison of group means of Purkinje cell density in Lobule X, an 
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Table 4.1. Number of seven-day surviving animals analyzed per treatment group. 
Injury TH Onset (Post-ROSC) 24-Hour TH 48-Hour TH Total 
Sham Normothermia N/A N/A 6 
CA Normothermia N/A N/A 6 
CA 0 Hours 10 9 19 
CA 1 Hours 8 7 15 
CA 4 Hours 9 6 15 
CA 8 Hours 3 3 6 
Total  30 25 67 
 
unpaired, one-tailed Student’s t Test was performed. One outlying value in the Purkinje 
cell density in the primary fissure of the cardiac arrest injured, normothermic group was 
identified and excluded according to the Grubbs test. The group mean including this 
value was 6.0 cells/mm, versus 3.8 cells/mm excluding the outlier. 
4.3. Results 
4.3.1. Effect of TH on Purkinje cell survival after cardiac arrest 
 
To survey the effect of cardiac arrest on cerebellar Purkinje cell survival, sagittal sections 
of the cerebellar vermis were labeled immunohistochemically using an antibody to 
calbindin, which is specific for Purkinje cells in the cerebellum. In sham animals, we 
detected regularly spaced, rounded cell bodies in the Purkinje layer and extensive 
dendritic arborizations in the molecular layer, each characteristic of Purkinje cells (Figure 
1A, D). In the normothermic post-cardiac arrest group, loss of calbindin-labeled Purkinje 
cell bodies and processes was apparent throughout most lobules and most consistently in 
the primary fissure (between Lobules V and VI) (Figure 1B, E).  In contrast, we observed 
no perceptible loss of calbindin-labeled Purkinje cells in Lobule X (Figure 1G-H).   
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Figure 4.1. Purkinje cell loss after cardiac arrest and protection with TH. Adult 
rats were subjected to sham injury (A, D, and G) or cardiac arrest and resuscitation 
followed by normothermia (B, E, and H) or TH (C and F). Seven days post-injury, 
transverse 50µm sections of the cerebellar vermis were immunolabeled using an 
antibody to the Purkinje cell-specific protein calbindin. A-C: Representative 
photomontages of the primary fissure after sham injury (A), cardiac arrest 
followed by normothermia (B), and cardiac arrest followed by TH initiated 
immediately after ROSC and maintained 48 hours (C) Scale bar is 250µm. D-F: 
Single image of the base of the primary fissure corresponding to A-C, respectively. 
Scale bar is 100µm. G-H: Representative photomontages of Lobule X after sham 
(G) and cardiac arrest followed by normothermia (H). Scale bar is 250µm. 
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Next, we examined whether post-cardiac arrest TH had a protective effect on cerebellar 
Purkinje cell survival. Animals in which TH was initiated immediately post-cardiac arrest 
and maintained for 48 hours appeared to have moderate neuroprotection based on 
calbindin immunolabeling (Figure 1C, F). Interestingly, Purkinje cells were not evenly 
distributed, but instead were composed of alternating regions of surviving cells and 
empty spaces.  
 
4.3.2. Quantification of Purkinje cell survival after cardiac arrest 
 
To quantify Purkinje cell survival, sagittal sections of the vermis were Nissl stained to 
label neuronal cell bodies. A representative region of the primary fissure from a sham-
injured rat is shown in Figure 2A. Purkinje cells were identified as large, rounded cells in 
the Purkinje layer. The density of Purkinje cells in the primary fissure was 35.9  2.4 
cells/mm in sham controls (Figure 2D). In cardiac arrest injured rats treated with 
normothermia, we observed extensive loss of Purkinje cells (Figure 2B). Purkinje cell 
density in the primary fissure was 3.8  1.8 cells/mm, approximately 11% of sham 
(Figure 2D; p < 0.001). Although considerable Purkinje cell loss occurred throughout the 
medial-lateral distribution of the vermis, cell death was greatest in mid-vermal sections 
(data not shown). We also quantified Purkinje cell density in Lobule X using Nissl-
stained cerebellar vermis as above. Purkinje cell density was 27.6  1.3 cells/mm in sham 
and 27.3  1.6 cells/mm in cardiac arrest injured, normothermia-treated rats (p=0.37; 
Figure 2G-I).  
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Figure 4.2. Quantification of Purkinje cell density in cerebella from sham-injured 
vs. cardiac arrest-injured rats treated with normothermia or TH.  A-C: 
representative images of the primary fissure from rats that underwent sham injury 
(A), cardiac arrest followed by normothermia (B), and cardiac arrest followed by TH 
initiated immediately after ROSC and maintained for 48 hours (C). Scale bar is 
100µm. D: Purkinje cell density in the primary fissure of sham injured rats compared 
to cardiac arrest followed by normothermia (Normo) or all TH treated combined (All 
TH), *p<0.001,. E: Comparison of 24-hour and 48-hour TH duration, *p<0.001, 
#p<0.05. F: Comparison of 0, 1, 4, and 8 hour TH onset time, *p<0.001, #p<0.05. G-
H: representative images of Lobule X from rats subjected to sham (G) or cardiac 
arrest injury followed by normothermia (H). Scale bar is 100µm. I: Purkinje cell 
density of Lobule X in sham injured rats compared to cardiac arrest followed by 
normothermia, p=0.37, Student’s T-test. 
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4.3.3. Impact of TH onset time and duration on Purkinje cell survival after cardiac 
arrest 
 
Next, we examined the effect of post-cardiac arrest TH onset time and duration on the 
degree of neuroprotection. Rats were block randomized to sham or cardiac arrest injury 
with normothermia or TH initiated at 0, 1, 4, or 8 hours post-cardiac arrest and 
maintained for 24 or 48 hours. All seven-day survivors were analyzed (Table 1). Figure 
2C shows a representative region of the primary fissure from an animal in which TH was 
initiated immediately post-cardiac arrest and maintained for 48 hours. Grouped together, 
hypothermia-treated post-cardiac arrest animals had a Purkinje cell density of 14.0  5.6 
cells/mm, nearly 39% of sham injured controls (Figure 2D, p < 0.001 compared to 
normothermia). When grouped by TH duration, Purkinje cell density was 12.5  4.0 
cells/mm with 24 hour TH and 15.5  5.6 cells/mm with 48-hour TH. (p = 0.002 and p < 
0.001, respectively compared to normothermia). While the density appeared greater for 
48-hour compared to 24-hour duration TH, the difference was not statistically significant 
(p=0.245). Finally, when grouped by onset time of 0, 1, 4, or 8-hours after ROSC, 
Purkinje cell density was 16.0  7.7, (p < 0.001 compared to normothermia), 11.9  2.9 
(p = 0.03), 13.1  4.6 (p = 0.006), and 14.8  3.3 (p = 0.007) cells/mm, respectively. 
However, no significant differences between TH onset times were detected. 
 
4.4. Discussion 
4.4.1. Post-cardiac arrest TH protects cerebellar Purkinje cells 
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To our knowledge, we are the first to report that post-cardiac arrest TH protects 
cerebellar Purkinje cells. Surprisingly, there was no significant difference in Purkinje cell 
survival between onset times from 0- to 8-hours post-ischaemia or durations of 24 or 48 
hours. Our results suggest that there is a critical period between 8 and 24 hours after 
ROSC when neurodegenerative processes in cerebellar Purkinje cells can be inhibited by 
TH.  However, there are a number of caveats to this conclusion. First, although surviving 
Purkinje cells possessed a normal nuclear and dendritic morphology in rats treated with 
TH, we did not measure the physiologic activity or extent of dendritic arborization of 
surviving Purkinje cells. Second, while TH treatment improved post-cardiac arrest 
Purkinje cell survival from 11% to 39% of sham-injured controls, there was still 
significant Purkinje cell loss seven days after cardiac arrest, suggesting the existence of 
injury pathways that were not responsive to TH as it was applied in this model.  Third, 
although TH was initiated immediately after ROSC in the 0-hour onset group, it took 30 
minutes to achieve target temperature of 33  1 C.  Therefore, TH achieved either during 
CPR or immediately after ROSC could provide additional neuroprotection (Takata et al., 
2005). Fourth, our asphyxial cardiac arrest model was designed to be severe (17% seven 
day survival with normothermia) in order to accurately replicate the human condition and 
to more easily measure the therapeutic benefits of post-ischaemic TH (Che et al., 2011). 
In addition, we selected the primary fissure of the vermis for quantification of Purkinje 
cell survival because it was the most consistently and severely injured region, presenting 
the greatest possibility of detecting differences between groups. In a more moderate 
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injury model with less severe Purkinje cell loss, post-ischaemic TH may provide more 
complete neuroprotection. 
4.4.2. Potential mechanisms underlying the insensitivity of Lobule X Purkinje cells to 
post-ischaemic degeneration 
 
The insensitivity of Lobule X Purkinje cells to cardiac arrest was striking compared to the 
extensive loss of Purkinje cells in the rest of the cerebellum. To our knowledge, we are 
the first to report this phenomenon in a global brain ischaemia model. However, the 
resistance of Lobule X Purkinje cells to degeneration has been reported in several 
neurodegenerative disease models, including Niemann-Pick disease type C1, genetic 
models of cerebellar ataxia, and neonatal viral infection (Sarna et al., 2003; Williams et 
al., 2007; Duffin et al., 2010). Lobule X Purkinje cell resistance to neurodegeneration has 
been attributed to differential gene expression in this region, particularly heat shock 
protein 25, zebrin II/Aldolase C, EAAT4, glutamate-aspartate transporter, and 
phospholipase C 4 (Armstrong et al., 2001; Welsh et al., 2002; Sarna et al., 2006; 
Yamashita et al., 2006; Duffin et al., 1010). Alternatively, the topography of synaptic 
connections in this region, referred to as the nodular zone, could also play a critical role 
(Heinsen and Heinsen, 1983; Ozol et al., 1999). Elucidating the underlying mechanisms 
of Purkinje cell survival in Lobule X could provide therapeutic strategies to protect 
Purkinje cells in vulnerable regions of the cerebellum after cardiac arrest. 
4.4.3. Comparison of TH-induced neuroprotection in the cerebellum to the hippocampus 
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In our original study, we analyzed the effect of post-cardiac arrest TH onset and duration 
on seven day animal survival and loss of hippocampal CA1 pyramidal neurons (Che et 
al., 2011). We found that animal survival was significantly greater in TH-treated animals 
with an onset time of 0-, 1-, and 4-hours, but not 8-hours. However, similar to Purkinje 
cells, we observed comparable protection of hippocampal CA1 pyramidal neurons when 
TH was initiated 0, 1, 4, or 8 hours after ROSC. CA1 pyramidal neuron survival was 
enhanced when TH was maintained for 48 hours compared to 24 hours.  Although we 
saw a similar trend of a TH duration effect for Purkinje cell survival, the difference was 
not statistically significant.  One potential explanation for this difference is that CA1 
pyramidal neuron degeneration could be more delayed relative to cerebellar Purkinje 
cells, and therefore might require a longer duration of therapy for optimal protection 
(Pulsinelli et al., 1982; Kirino et al., 1984; Dux et al., 1987; Welsh et al., 2002). 
4.4.4. Implications for neurologic outcomes after cardiac arrest.   
The clinical implications of Purkinje cell loss after cardiac arrest have yet to be fully 
elucidated.  Posthypoxic myoclonus is mechanistically complex and thought to involve 
multiple brain regions including the cerebral cortex, basal ganglia, thalamus, 
hippocampus, brainstem and cerebellum (Venkatesan and Frucht, 2006).
  
The 
contribution of cerebellar pathology
 
is supported by the work of Welsh et al. (2006), who 
recapitulated myoclonus behavior in rats by inducing patterned Purkinje cell death using 
the neurotoxic compound ibogaine. It has been hypothesized that the abnormal excitatory 
activity responsible for post-hypoxic myoclonus is generated in the brainstem, and that 
loss of Purkinje cells in a concentrated region could remove the basal inhibition of deep 
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cerebellar nuclei that project to the brainstem (Welsh et al., 2002; Venkatesan and Frucht, 
2006). Although not as well documented in cardiac arrest studies, ataxia is strongly 
correlated with Purkinje cell loss in number of clinical disorders including with 
spinocerebellar ataxia, alcoholic cerebellar degeneration, Niemann-Pick disease type C1, 
and paraneoplastic cerebellar degeneration (Walkley et al., 2004; Yokota et al., 2006; 
Metha et al., 2009). Additionally, selective Purkinje cell degeneration has been shown to 
cause ataxia in animal models of spinocerebellar ataxia, Niemann-Pick disease type C1,
 
and chronic ethanol exposure (Tavares et al., 1987; Watase et al., 2002; Aguiar et al., 
2006; Lopez et al., 2011; Shakkottai et al., 2011). Currently, a better understanding of the 
contribution of cerebellar injury on neurologic outcome after cardiac arrest is needed.  
Moving forward, it will be important to examine the effect of post-cardiac arrest TH on 
the incidence and severity of neurologic disorders such as post-hypoxic myoclonus and 
ataxia in animal and human studies.   
4.4.5. Conclusions 
Our results demonstrate that post-cardiac arrest TH protects selectively vulnerable 
cerebellar Purkinje cells.  Moreover, TH appears to exert its greatest protective effect on 
Purkinje cell survival between 8 and 24 hours after ROSC. These results underscore the 
importance of considering multiple brain regions when optimizing the neuroprotective 
effect of post-cardiac arrest TH.  Finally, the impact of post-cardiac arrest TH on 
cerebellar function in humans warrants more in-depth examination.  
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CONCLUSIONS 
 
5.1. Introduction 
 
Brain injury after cardiac arrest is a significant contributor to mortality and neurologic 
dysfunction. Multiple factors are thought to influence the pathway of post-ischemic 
neurodegeneration, including excitatory input, inflammation, Ca
2+
i homeostasis, 
mitochondrial dysfunction, and calpain activity (see Chapter 1.3). Previous studies using 
genetic manipulation showed that calpain activity causes hippocampal CA1 pyramidal 
neuron death after global ischemia (Cao et al., 2007; Bevers et al., 2010). Based on these 
results, the role of calpain activity in mitochondrial dysfunction was examined by 
characterizing the proteolysis of ETC subunits by an endogenous mitochondrial protease. 
In addition, the role of calpain activity in post-ischemic neurodegeneration of cerebellar 
Purkinje cells was explored. Finally, the optimal parameters of TH, which has broad 
effects on factors related to post-ischemic neurodegeneration, were examined in 
cerebellar Purkinje cells. The results of each study provide a small contribution to our 
understanding of neuronal death mechanisms after global brain ischemia. 
5.2. Proteolysis of ETC subunits by a mitochondrial cysteine protease—likely calpain 
10—occurs after global and focal brain ischemia 
 
Despite significant contributions to the characterization of the protease responsible for 
proteolytic activity of ETC subunits, the identity of the protease is not entirely clear. 
Proteolysis of ETC subunits NDUFB8 and Complex V could be induced in vitro and 
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was detected after global and focal ischemia in vivo (see Chapter 2). As a reducing 
environment is required for activity and a variety of cysteine protease inhibitor drugs 
block ETC proteolysis, there is clear evidence that it is a cysteine protease. Based on the 
literature regarding ETC subunit proteolysis and inhibition by CYGAK, the inhibitor 
profile of this protease is consistent with calpain 10 (Arrington et al., 2006; Rasbach et 
al., 2009). The pH optimum, inhibition by cathepsin-specific inhibitor Z-FF-FMK, and 
Ca
2+
-independence of proteolytic activity are not consistent with the definition of calpain 
proteases. However, calpain 10 is an atypical calpain, which does not share sequence 
homology with the Ca
2+
-binding motifs of classical calpains 1 and 2 (See Figure 2.3). It 
is possible that calpain 10 could possess a different mechanism of physiologic activation 
than typical calpain isoforms.  
Future studies to identify the mitochondrial protease could be performed utilizing a 
protease probe strategy (Greenbaum et al., 2000). Greenbaum et al. typically utilize 
biotin-conjugated version of the protease inhibitor E-64c to covalently bind and isolate 
active cysteine proteases. Unfortunately, mitochondria are extensively biotinylated, so 
much so that endogenous biotin can be utilized as a mitochondrial marker (Coene et al., 
2008). An alternative approach is to use a fluorophore-conjugated version of E-64c 
(Greenbaum et al., 2002). Although my attempts in collaboration with Dr. D.C. 
Greenbaum have been met with technical difficulties, this approach has great promise to 
identify the mitochondrial cysteine proteases activated in our in vitro model. 
An alternative strategy to determine whether calpain 10 specifically is responsible for 
ETC proteolysis is to reduce or enhance its expression in a cell culture system and 
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compare the rate of proteolysis to mitochondria isolated from control cells. 
Overexpression of calpain 10 has been performed in cell culture, resulting in 
mitochondrial swelling and autophagy (Arrington et al., 2006). RNA interference of 
calpain 10 has been performed rabbit renal proximal tubular cells in vivo, resulting in 
mitochondrial dysfunction, increased mitochondrial fission and decreased fusion, and 
activation of apoptosis (Covington et al., 2009; Smith et al., 2012). Additionally, a 
calpain-10 knockout mouse has been generated, but the molecular weight of the 
eliminated protein is not consistent with the reported size of calpain 10 (Johnson et al., 
2004; Arrington et al., 2006). 
Characterization of calpain 10 activity is of great importance due to correlation of 
polymorphisms in the calpain 10 gene with type 2 diabetes mellitus (Horikawa et al., 
2000; Weedon et al., 2003). If the mitochondrial protease is proven to be calpain 10, if 
would be interesting to determine whether ETC subunit proteolysis plays any role in the 
pathology of diabetes mellitus. Polymorphisms in the calpain 10 gene have been 
correlated with increased type 2 diabetes risk (Horikawa et al., 2000; Horikawa, 2006). 
Perhaps these polymorphisms or other mutations of the calpain 10 gene could help to 
determine the physiologic function of the protease. 
 
5.3. Functional calpain knockdown did not reduce Purkinje cell neurodegeneration 
48-hours after cardiac arrest 
 
Calpain-mediated proteolysis, as detected by the calpain-specific cleavage fragment of 
spectrin, has been detected in models of global ischemia-reperfusion in a timecourse 
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preceding neurodegeneration in SVN populations including the hippocampus, striatum, 
frontal cortex, thalamus, and cerebellum (Roberts-Lewis et al., 1994; Neumar et al., 
2001; Kopil et al., 2011). However, evidence for a causal role of calpain activity in 
neurodegeneration after global ischemia was limited in vivo to the CA1 pyramidal 
neurons of the hippocampus (Cao et al., 2007; Bevers et al., 2010). I sought to determine 
whether our understanding of calpain-mediated post-ischemic neuronal death could be 
applied to a different SVN population, the Purkinje cells of the cerebellum. I detected 
significant calpain-mediated proteolysis in Purkinje cells one hour post-ROSC and 
successfully reduced cardiac arrest-induced calpain activity in Purkinje cells in vivo 
utilizing an RNA interference strategy to reduce expression of the calpain regulatory 
subunit Capns1. However, Capns1 knockdown did not result in reduced Purkinje cell 
neurodegeneration measured by FluoroJade staining 48 hours post-ROSC. The caveats to 
this set of experiments have been discussed (see Chapter 3.4).  
One critical next step will be to validate that Capns1 knockdown can reduce calpain-
mediated post-ischemic neurodegeneration. In parallel with the intracerebellar injections, 
one hemisphere of the hippocampus was also injected with AAV2/9 vector expressing 
shRNA targeting capns1 or a scramble control sequence. Further analysis can be 
performed to examine whether this RNA interference approach reduced calpain activity 
and neurodegeneration of hippocampal CA1 pyramidal neurons from the same rats. 
Bevers et al. (2010) established that shRNA-mediated knockdown of calpain 1 blocked 
calpain activity, reduced neurodegeneration, and improved physiologic function of CA1 
pyramidal neurons after transient forebrain ischemia. If Capns1 knockdown in a model of 
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cardiac arrest provides the same neuroprotection, two possibilities remain to explain the 
lack of neuroprotection of Purkinje cells of the cerebellum. First, there could be a greater 
degree of Ca
2+
i overload in the cerebellum than the hippocampus, such that a 
manipulation that protects CA1 pyramidal neurons is not sufficient to protect Purkinje 
cells against high Ca
2+
i-induced mitochondrial dysfunction, ROS production, or ER stress 
(Dong et al., 2006). The accelerated time-course of delayed calpain activity and 
neurodegeneration in Purkinje cells relative to CA1 pyramidal neurons provides some 
evidence that this might be the case (Kopil et al., 2011; Frederick et al., 2008; Neumar et 
al., 2001).  
Alternatively, global ischemia-reperfusion injury may activate other mechanisms of 
neurodegeneration that are critical to Purkinje cell death. There is evidence indicating 
that the excitatory synaptic input of the climbing fiber pathway from the inferior olive to 
Purkinje cell dendritic arborizations is hyperactive in an in vivo model of cardiac arrest, 
and that removal of this synaptic input protects against Purkinje cell loss (Welsh et al., 
2002). Future studies could examine the role of inflammation, oxidative stress, 
mitochondrial dysfunction, and alternative mechanisms of Ca
2+
-mediated cell death in 
Purkinje cell degeneration.  
 
5.4. Therapeutic hypothermia protects cerebellar Purkinje cells after cardiac arrest 
 
Previous evidence indicated that 48-hour duration TH provided greater neuroprotection 
of hippocampal CA1 pyramidal neurons than 24-hour duration TH, but both were 
significantly neuroprotective compared to normothermia (Che et al., 2010). However, in 
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the cerebellum, both durations were equally neuroprotective. In addition, onset of TH 
between 0-8 hours after cardiac arrest provided similar neuroprotection in both brain 
regions. One caveat to this result is that rats initially treated with TH reached target 
temperature 30 minutes after onset time, not immediately. As there is evidence for a 
therapeutic benefit of TH achieved immediately upon ROSC (Kuboyama et al., 1993; 
Abella et al., 2004; Takata et al., 2005), it would be interesting to determine the effect of 
immediate cooling on Purkinje cell survival, as well as whether there is a synergistic 
effect of immediate and prolonged TH. 
5.4.1. Potential extrinsic factors causing differential vulnerability of Lobule X Purkinje 
cells to global ischemia-reperfusion injury. 
 
The lack of Purkinje cell loss in Lobule X after cardiac arrest provides an excellent 
comparitor to determine the mechanisms responsible for post-ischemic Purkinje cell 
neurodegeneration. First, it is possible that Lobule X is less vulnerable due to a lack of 
excitatory stimulus. Welsh et al. (2002) detected increased excitation of the climbing 
fiber pathway via EEG recording of the hindbrain. This method lacked the sensitivity to 
determine the localization of this overexcitation. One could insert electrodes into 
vulnerable and invulnerable lobules of cerebellum for in vivo recording of field excitatory 
postsynaptic potentials (fEPSP’s) or single unit firing of Purkinje cells after ROSC. 
While use of this technique is uncommon in the cerebellum, it has been demonstrated in a 
mouse model (Cheron et al., 2009). If hyperexcitation of Purkinje cells is part of the 
pathway of neuronal death, it should be possible to predict the regions of degenerating 
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neurons based on the rate and magnitude of fEPSP’s in the molecular layer as well as the 
Purkinje cell firing rate. 
Second, the migration of activated microglia could be compared between different 
lobules of the cerebellum. However, one could expect that only cerebellar regions that 
possess cell death would recruit inflammatory cells to the site of injury. Therefore, while 
inflammation may take part in a feed-forward pathway of post-ischemic neuronal death, 
an unaffected region of the brain may provide an insufficient comparator. 
5.4.2. Potential intrinsic factors causing differential vulnerability of Lobule X Purkinje 
cells to global ischemia-reperfusion injury. 
 
Multiple genes are differentially expressed between Lobule X Purkinje cells and other 
lobules. In addition, striations of differential gene expression occur within lobules that are 
selectively vulnerable to global ischemia. These genes could be involved in a number of 
intrinsic factors that play a role in post-ischemic Purkinje cell death. Overexpression or 
knockdown of each of these genes in selectively vulnerable regions of Purkinje cells 
could provide insight into their role in ischemic brain injury, as well as the mechanisms 
that are critical for Purkinje cell neurodegeneration. Laser-capture microdissection or live 
tissue fluorescence-activated cell sorting (FACS) could be used to isolate Purkinje cells 
from cerebellar tissue, followed by proteomic or transcriptomic approaches to generate a 
comprehensive list of differentially expressed genes in Purkinje cells between Lobule X 
and other cerebellar lobules (Guez-Barber et al., 2012; Kuhn et al., 2012). Of each of the 
genes currently known to be differentially expressed among Purkinje cells, their potential 
roles in post-ischemic neurodegeneration are discussed below. 
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Zebrin II/Aldolase C was the first protein discovered to have a striated expression among 
cerebellar Purkinje cells (Brochu et al., 1990). Aldolase C is an enzyme in the glycolysis 
pathway, hydrolyzing fructose-1,6-bisphosphate into dyhydroxyacetone phosphate and 
glyceraldehyde-3-phosphate. It is possible that greater expression of Aldolase C could 
increase energy metabolism to protect Purkinje cells under stressful conditions. As a non-
rate-limiting enzyme in the glycolysis pathway, its role in neuroprotection may be 
minimal. However, expression of this protein can be used to mark striations within 
vulnerable lobules, or to separate pools of Purkinje cells via FACS (Welsh et al., 2002; 
Guez-Barber et al., 2012).   
Heat shock protein-25 (HSP-25) was found to have a patterned expression in mouse 
cerebellar Purkinje cells (Armstrong et al., 2001). HSP-25 is expressed in the cytosol, 
then translocates to the nucleus upon thermal stimulation (Geum et al., 2002). It interacts 
with heat-destabilized actin to prevent aggregation, and HSP-25 is thought to maintain 
the structure of the nucleus upon thermal stress (Geum et al., 2002; Panasenko et al., 
2003). Expression of HSP-25 in Purkinje cells is correlated with protection against 
neuronal death in the lurcher mouse model (Duffin et al., 2010). 
EAAT4 is more strongly expressed in Aldolase C-positive Purkinje cells and is localized 
primarily extrasynaptically on the dendritic plasma membrane (Dehnes et al., 1998; 
Welsh et al., 2002). Although it is nominally a transporter, it acts as an anionic channel 
when bound to glutamate (Dehnes et al., 1998). In mice genetically manipulated to knock 
out expression of the GLAST—an astrocytic membrane protein responsible from 
clearance of glutamate from the synapse and the extracellular space—Purkinje cells 
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expressing less EAAT4 preferentially lost due to mild global ischemic injury, in which 
WT mice did not lose Purkinje cells, suggesting that EAAT4 protects Purkinje cells from 
glutamatergic excitotoxicity (Yamashita et al., 2006). 
Phospholipase C (PLC) 3 and β4 are uniquely and strongly expressed in mouse 
cerebellum (Sarna et al., 2006). Each isoform is responsible for production of IP3 and 
diacylglycerol from phosphatidylinositol 4,5-bisphosphate when activated by a seven-
transmembrane receptor (Kim et al., 1997). It is possible that expression of PLC 3 or β4 
isoforms could influence Ca
2+
i homeostasis via IP3 receptor-mediated release of Ca
2+
 
from the ER. 
5.5. Conclusion 
 
Examination of individual mediators of post-ischemic neurodegeneration have 
demonstrated the importance of each mechanism in the pathway of neuronal death in 
SVN populations. However, these factors likely overlap in their contribution to 
neurodegeneration. This may explain why no treatment targeting any individual factor 
has been proven in a clinical trial as an effective therapeutic strategy to improve patient 
survival and neurologic outcome after cardiac arrest. It is also important to note that 
cardiac arrest is a whole-body injury—while brain injury is a key contributor to patient 
outcome, it is one among many organ systems injured by global ischemia-reperfusion 
(Reynolds and Lawner, 2012). Currently, TH, which has broad effects influencing 
multiple factors involved in ischemia-reperfusion injury, is the only successful clinically 
approved therapy after cardiac arrest (Bernard et al., 2002; Hypothermia after Cardiac 
Arrest Study Group, 2002). Although specific targeting of an individual factor involved 
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in post-ischemic neurodegeneration has not been successful, perhaps a combined therapy 
targeting multiple mechanisms of neurodegeneration—perhaps in concert with TH—
could provide additional therapeutic benefit after cardiac arrest. 
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APPENDIX 1: List of Abbreviations 
 
AAV Adeno-associated virus 
AIF Apoptosis inducing factor 
ANOVA Analysis of variance 
BME mercaptoethanol 
BSA Bovine serum albumin 
BSL-1 Biosafety level 1 
Ca
2+
i Intracellular ionic calcium 
[Ca
2+
]m Concentration of mitochondrial ionic calcium 
Capns1 Calpain small subunit 1 
CB7 Chicken β-actin promoter with cytomegalovirus enhancer 
CBF Cerebral blood flow 
Complex Va Complex V subunit a 
CPR Cardiopulmonary resuscitation 
DIV Days in vitro 
EAAT4 Excitatory amino acid transporter-4 
ER Endoplasmic reticulum 
ETC Electron transport chain 
FACS Fluorescence-associated cell sorting 
fEPSP’s Field excitatory postsynaptic potentials 
GC Genome copies 
GLAST Glutamate aspartate transporter 
hU6 Human U6 promoter 
IM Inner membrane of the mitochondrion 
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IMS Intermembrane space of the mitochondrion 
IP3 Inositol-1,4,5-triphosphate 
KPi Potassium phosphate 
LDF Laser-doppler flow 
LGMD2A Limb-girdle muscular dystrophy type 2A 
MAP Mean arterial pressure 
MCA Middle cerebral artery 
MCAO Middle cerebral arterial occlusion 
MPT Mitochondrial permeability transition 
NDUFB8 NADH dehydrogenase (ubiquinone) 1 β subcomplex 8 
NDUFV2 NADH dehydrogenase (ubiquinone) flavoprotein 2 
ROS Reactive oxygen species 
ROSC Return of spontaneous circulation 
Scr Scramble 
SDS Sodium dodecyl sulfide 
shRNA Short hairpin RNA 
SMP Sub-mitochondrial particle 
SVN Selectively vulnerable neuron 
TFI Transient forebrain ischemia 
TH Therapeutic hypothermia 
VDAC Voltage-dependent anion channel 
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